Cencora, Inc. (COR)
Conshohocken, PA, US
Cencora, Inc. functions as a global leader in the sourcing and distribution of pharmaceutical products, with operations spanning both the United States and international markets. Within its U.S. Healthcare Solutions segment, the company supplies a broad spectrum of pharmaceutical items, including generic and injectable medications, over-the-counter health products, and home healthcare equipment. Its extensive client network includes acute care hospitals, health systems, a variety of retail and mail-order pharmacies (independent, chain, long-term care), medical clinics, and other healthcare providers. This division also manages the distribution of crucial specialized pharmaceutical products like plasma, blood derivatives, and vaccines. Beyond product supply, Cencora offers comprehensive support services, such as pharmacy management, staffing solutions, and strategic consulting. It develops and implements supply management software, provides packaging services for both institutional and retail healthcare settings, and assists with clinical trial support, post-market approval processes, and commercialization strategies. For biotechnology and pharmaceutical manufacturers, the company delivers data analytics, outcomes research, and other specialized services. Furthermore, Cencora serves the animal health market, providing pharmaceuticals, vaccines, parasiticides, diagnostics, and micro feed ingredients for both companion and production animals. It also offers sales force support to manufacturers and specialized services to medical professionals, particularly oncologists, as well as to hospitals and dialysis clinics. The International Healthcare Solutions division concentrates on global pharmaceutical wholesale activities, associated services, and worldwide commercialization support. It ensures the efficient distribution of medicines, various healthcare goods, and related services to an international customer base comprising pharmacies, doctors, health centers, and hospitals. This segment also delivers specialized transportation and logistics solutions specifically designed for the biopharmaceutical sector. Founded in 1871, the company was formerly known as AmerisourceBergen Corporation before adopting the name Cencora, Inc. in August 2023. Its corporate headquarters are situated in Conshohocken, Pennsylvania.
No mergers or acquisitions recorded for this company.
Index membership
| Index | Added | Removed | Status |
|---|---|---|---|
| S&P 500 | 2001-08-29 | — | Active |
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| +0.47% | +2.83% | -18.67% | -25.67% | -28.20% | -22.74% | -6.27% | +52.60% | +117.28% | +248.93% | +8,745.08% |
Revenue flow
Revenue by geography
Revenue by segment
Revenue composition
By product
By geography
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
DCF figures are point estimates: small changes in growth or discount-rate assumptions move them materially. Read them as a reference, not a precise target.
| Rating | 2026-05 | Change |
|---|---|---|
| Strong Buy | 3 | 0 |
| Buy | 8 | 0 |
| Hold | 3 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
| Period | # Analysts | Avg Target |
|---|---|---|
| Last Month | 1 |
360.00
+18.7%
|
| Last Quarter | 4 |
398.50
+31.4%
|
| Last Year | 18 |
386.33
+27.4%
|
| All Time | 43 |
278.70
-8.1%
|
-
Revenue growth Medical - Distribution: +5.6%+9.3% ★ Q1'26: +3.8% (vs Q1'25)
-
EPS growth Medical - Distribution: +4.9%+5.7% ★ Q1'26: +128.3% (vs Q1'25)
-
FCF margin FCF growth · Medical - Distribution: +37.6%+0.6% Q1'26: +1.5% (vs Q1'25)
-
EBIT margin Medical - Distribution: +3.0%+0.8% Q1'26: +1.7% (vs Q1'25)
-
ROIC Medical - Distribution: +5.7%+23.0% ★ Q1'26: +30.6% (vs Q1'25)
-
Share dilution Medical - Distribution: +0.0%-2.5% ★ Q1'26: +0.1% (vs Q1'25)
-
Debt / EBITDA Net debt/EBITDA · Medical - Distribution: 0.87×2.88× Q1'26: 1.93× (vs Q1'25)
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
| Metric |
Sep 2011 actual |
Sep 2012 actual |
Sep 2013 actual |
Sep 2014 actual |
Sep 2015 actual |
Sep 2016 actual |
Sep 2017 actual |
Sep 2018 actual |
Sep 2019 actual |
Sep 2020 actual |
Sep 2021 actual |
Sep 2022 actual |
Sep 2023 actual |
Sep 2024 actual |
Sep 2025 actual |
Sep 2026 10 Rev. Ana. 8 EPS Ana. |
Sep 2027 10 Rev. Ana. 8 EPS Ana. |
Sep 2028 9 Rev. Ana. 3 EPS Ana. |
Sep 2029 7 Rev. Ana. 1 EPS Ana. |
Sep 2030 8 Rev. Ana. 1 EPS Ana. |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue |
80.22B
est: 308.44M (+25,907.6%)
|
79.49B
est: 140.86M (+56,330.0%)
|
87.96B
est: 163.36M (+53,745.2%)
|
119.57B
est: 199.62M (+59,799.8%)
|
135.96B
est: 134.92B (+0.8%)
|
146.85B
est: 147.21B (-0.2%)
|
153.14B
est: 154.15B (-0.7%)
|
167.94B
est: 167.89B (+0.0%)
|
179.59B
est: 179.18B (+0.2%)
|
189.89B
est: 188.71B (+0.6%)
|
213.99B
est: 212.20B (+0.8%)
|
238.59B
est: 237.88B (+0.3%)
|
262.17B
est: 276.54B (-5.2%)
|
293.96B
est: 292.54B (+0.5%)
|
321.33B
est: 321.05B (+0.1%)
|
339.06B
332.80B – 341.84B
+5.6% YoY
|
359.32B
349.75B – 364.33B
+6.0% YoY
|
383.37B
382.71B – 384.03B
+6.7% YoY
|
425.66B
416.33B – 434.70B
+11.0% YoY
|
477.84B
467.36B – 487.98B
+12.3% YoY
|
| EBITDA |
1.33B
est: 108.83M (+1,122.8%)
|
1.40B
est: 117.10M (+1,097.6%)
|
1.07B
est: 49.89M (+2,035.3%)
|
939.18M
est: 74.13M (+1,166.9%)
|
630.77M
est: 119.92M (+426.0%)
|
1.92B
est: 155.11M (+1,138.0%)
|
1.49B
est: 223.01M (+568.1%)
|
1.87B
est: 245.07M (+661.7%)
|
1.65B
est: 274.74M (+501.0%)
|
-4.73B
est: 256.07M (-1,948.6%)
|
2.91B
est: 292.43M (+895.0%)
|
3.11B
est: 321.67M (+867.7%)
|
3.41B
est: 3.47B (-1.7%)
|
3.36B
est: 3.67B (-8.3%)
|
3.74B
est: 4.03B (-7.2%)
|
4.25B
4.17B – 4.29B
+5.6% YoY
|
4.51B
4.39B – 4.57B
+6.0% YoY
|
4.81B
4.80B – 4.82B
+6.7% YoY
|
5.34B
5.22B – 5.45B
+11.0% YoY
|
5.99B
5.86B – 6.12B
+12.3% YoY
|
| EBIT |
1.21B
est: -4.92M (+24,676.2%)
|
1.26B
est: 20.85M (+5,943.6%)
|
899.51M
est: 20.05M (+4,387.2%)
|
751.13M
est: 31.58M (+2,278.5%)
|
380.99M
est: 57.16M (+566.5%)
|
1.54B
est: 81.82M (+1,776.3%)
|
1.07B
est: 122.83M (+768.6%)
|
1.37B
est: 138.26M (+888.8%)
|
1.16B
est: 144.80M (+702.9%)
|
-5.14B
est: 123.60M (-4,254.8%)
|
2.40B
est: 135.53M (+1,674.0%)
|
2.42B
est: 149.09M (+1,519.9%)
|
2.44B
est: 2.58B (-5.6%)
|
2.25B
est: 2.73B (-17.5%)
|
2.68B
est: 3.00B (-10.6%)
|
3.16B
3.10B – 3.19B
+5.6% YoY
|
3.35B
3.26B – 3.40B
+6.0% YoY
|
3.58B
3.57B – 3.58B
+6.7% YoY
|
3.97B
3.88B – 4.06B
+11.0% YoY
|
4.46B
4.36B – 4.55B
+12.3% YoY
|
| Net Income |
706.62M
est: -4.46M (+15,932.9%)
|
718.99M
est: 6.10M (+11,691.2%)
|
433.71M
est: 10.91M (+3,873.6%)
|
276.48M
est: 15.81M (+1,648.3%)
|
-134.89M
est: 30.85M (-537.2%)
|
1.43B
est: 50.80M (+2,710.6%)
|
414.48M
est: 73.75M (+462.0%)
|
1.66B
est: 75.71M (+2,090.4%)
|
855.37M
est: 77.99M (+996.7%)
|
-3.40B
est: 69.98M (-4,957.6%)
|
1.54B
est: 82.85M (+1,758.6%)
|
1.70B
est: 91.14M (+1,764.0%)
|
1.75B
est: 1.79B (-2.6%)
|
1.51B
est: 2.66B (-43.3%)
|
1.55B
est: 3.11B (-50.0%)
|
3.46B
3.43B – 3.49B
+11.3% YoY
|
3.85B
3.76B – 3.93B
+11.1% YoY
|
4.32B
3.89B – 4.76B
+12.5% YoY
|
4.77B
4.63B – 4.90B
+10.3% YoY
|
5.43B
5.28B – 5.58B
+13.9% YoY
|
| SGA |
1.20B
est: 74.98M (+1,497.8%)
|
1.23B
est: 89.33M (+1,276.3%)
|
1.33B
est: 35.78M (+3,627.8%)
|
1.59B
est: 44.21M (+3,490.3%)
|
1.91B
est: 62.95M (+2,930.8%)
|
2.09B
est: 65.34M (+3,100.4%)
|
2.13B
est: 78.51M (+2,611.5%)
|
2.46B
est: 86.27M (+2,751.8%)
|
2.66B
est: 101.60M (+2,521.6%)
|
2.77B
est: 92.37M (+2,895.8%)
|
3.59B
est: 100.31M (+3,483.0%)
|
4.85B
est: 110.34M (+4,294.4%)
|
5.31B
est: 5.36B (-0.9%)
|
5.66B
est: 5.67B (-0.1%)
|
6.49B
est: 6.22B (+4.4%)
|
6.57B
6.45B – 6.62B
+5.6% YoY
|
6.96B
6.77B – 7.06B
+6.0% YoY
|
7.43B
7.41B – 7.44B
+6.7% YoY
|
8.24B
8.06B – 8.42B
+11.0% YoY
|
9.25B
9.05B – 9.45B
+12.3% YoY
|
| EPS |
2.59
est: -0.63 (+514.4%)
|
2.84
est: 0.04 (+8,014.3%)
|
1.88
est: 0.20 (+864.1%)
|
1.22
est: 0.37 (+234.2%)
|
-0.62
est: 4.97 (-112.5%)
|
6.73
est: 5.55 (+21.4%)
|
1.67
est: 5.88 (-71.6%)
|
7.61
est: 6.48 (+17.4%)
|
4.07
est: 7.05 (-42.3%)
|
-16.60
est: 7.87 (-311.0%)
|
7.48
est: 9.23 (-19.0%)
|
8.15
est: 11.00 (-25.9%)
|
8.62
est: 9.23 (-6.6%)
|
7.60
est: 13.65 (-44.3%)
|
8.02
est: 15.94 (-49.7%)
|
17.74
17.58 – 17.89
+11.3% YoY
|
19.70
19.28 – 20.12
+11.0% YoY
|
21.86
19.93 – 24.38
+11.0% YoY
|
24.44
23.74 – 25.11
+11.8% YoY
|
27.84
27.05 – 28.61
+13.9% YoY
|
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-12 | B+ | 3/5 | 5/5 | 5/5 | 4/5 | 1/5 | 2/5 | 1/5 |
| 2026-05-11 | B+ | 3/5 | 5/5 | 5/5 | 4/5 | 1/5 | 2/5 | 1/5 |
| 2026-05-08 | B+ | 3/5 | 5/5 | 5/5 | 4/5 | 1/5 | 2/5 | 1/5 |
| 2026-05-07 | B+ | 3/5 | 5/5 | 5/5 | 4/5 | 1/5 | 2/5 | 1/5 |
| 2026-05-06 | B+ | 3/5 | 5/5 | 5/5 | 4/5 | 1/5 | 2/5 | 1/5 |
| 2026-05-05 | B+ | 3/5 | 5/5 | 5/5 | 4/5 | 1/5 | 2/5 | 1/5 |
| 2026-05-04 | B+ | 3/5 | 5/5 | 5/5 | 4/5 | 1/5 | 2/5 | 1/5 |
| 2026-05-01 | B+ | 3/5 | 5/5 | 5/5 | 4/5 | 1/5 | 2/5 | 1/5 |
| 2026-04-30 | B+ | 3/5 | 5/5 | 5/5 | 4/5 | 1/5 | 2/5 | 1/5 |
| 2026-04-29 | B+ | 3/5 | 5/5 | 5/5 | 4/5 | 1/5 | 2/5 | 1/5 |
| 2026-04-28 | B+ | 3/5 | 5/5 | 5/5 | 4/5 | 1/5 | 2/5 | 1/5 |
| 2026-04-27 | B+ | 3/5 | 5/5 | 5/5 | 4/5 | 1/5 | 2/5 | 1/5 |
| 2026-04-24 | B+ | 3/5 | 5/5 | 5/5 | 4/5 | 1/5 | 2/5 | 1/5 |
| 2026-04-23 | B | 3/5 | 5/5 | 5/5 | 4/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-22 | B | 3/5 | 5/5 | 5/5 | 4/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-21 | B | 3/5 | 5/5 | 5/5 | 4/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-20 | B | 3/5 | 5/5 | 5/5 | 4/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-17 | B | 3/5 | 5/5 | 5/5 | 4/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-16 | B | 3/5 | 5/5 | 5/5 | 4/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-15 | B | 3/5 | 5/5 | 5/5 | 4/5 | 1/5 | 1/5 | 1/5 |
Owner Earnings
Ownership Overview
| # | Reporting person | Amount owned | % of class | Sole voting | Shared voting | Sole dispositive | Shared dispositive | Type | Citizenship | Filing date | SEC filing |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | WBA Investments, Inc. | 33.09M | 16.38% | — | 33.09M | — | 10.00 | CO | — | 2023-06-20 | ↗ |
| 2 | Walgreens Boots Alliance Holdings LLC | 33.09M | 16.38% | — | 33.09M | — | 33.09M | OO | — | 2023-06-20 | ↗ |
| 3 | Walgreens Boots Alliance, Inc. | 33.09M | 16.38% | — | 33.09M | — | 10.00 | HC, CO | — | 2023-06-20 | ↗ |
| 4 | BlackRock for purposes of Schedule 13G filings. | 26.54M | 9.21% | 26.54M | — | 26.54M | — | HC | Delaware | 2010-01-29 | ↗ |
| 5 | (1) BlackRock, Inc. | 13.04M | 6.30% | 11.46M | — | 13.04M | — | HC | Delaware | 2022-02-03 | ↗ |
| 6 | (on behalf of its investment advisory subsidiaries - See Item 7) | 8.27M | 5.30% | — | 8.27M | — | — | IA, HC | NUMBER OF SHARES BENEFICALLY OWNED BY EACH REPORTING PERSON WITH | 2009-02-10 | ↗ |
| 7 | 04-2747644 | 2.43M | 5.70% | 2.41M | — | 2.43M | — | IA | Delaware | 2021-02-11 | ↗ |
| 8 | Edward C. Johnson 3d | 2.41M | 11.40% | — | — | 2.41M | — | IN | Delaware | 2012-11-13 | ↗ |
| 9 | FMR LLC | 2.41M | 11.40% | 245.8K | — | 2.41M | — | HC | Delaware | 2012-11-13 | ↗ |
| 10 | The Vanguard Group Inc. - 23-1945930 | 2.00M | 10.05% | — | — | 1.97M | 24.3K | IA | Pennsylvania | 2011-09-08 | ↗ |
| 11 | LLC 04-3519872 | 1.75M | 8.20% | 1.58M | — | 1.75M | — | IA | Delaware | 2014-02-06 | ↗ |
| 12 | AB Acquisitions Holdings Limited | — | 0.00% | — | — | — | 10.00 | OO | Gibraltar | 2015-01-23 | ↗ |
| 13 | Alliance Santé Participations S.A. | — | 0.00% | — | — | — | 10.00 | CO | Grand Duchy of Luxembourg | 2015-01-23 | ↗ |
| 14 | George R. Roberts | — | 0.00% | — | — | — | 10.00 | IN | United States | 2015-01-23 | ↗ |
| 15 | Henry R. Kravis | — | 0.00% | — | — | — | 10.00 | IN | United States | 2015-01-23 | ↗ |
| 16 | Janus Capital Management LLC | — | 0.00% | — | — | — | — | IA, HC | Delaware | 2003-12-11 | ↗ |
| 17 | KKR & Co. L.P. | — | 0.00% | — | — | — | 10.00 | PN | Cayman Islands | 2015-01-23 | ↗ |
| 18 | KKR 2006 Fund (Overseas), Limited Partnership | — | 0.00% | — | — | — | 10.00 | PN | Cayman Islands | 2015-01-23 | ↗ |
| 19 | KKR 2006 Limited | — | 0.00% | — | — | — | 10.00 | CO | Cayman Islands | 2015-01-23 | ↗ |
| 20 | KKR Associates 2006 (Overseas), Limited Partnership | — | 0.00% | — | — | — | 10.00 | PN | Cayman Islands | 2015-01-23 | ↗ |
| 21 | KKR Associates Europe II, Limited Partnership | — | 0.00% | — | — | — | 10.00 | PN | Cayman Islands | 2015-01-23 | ↗ |
| 22 | KKR Europe II Limited | — | 0.00% | — | — | — | 10.00 | CO | Cayman Islands | 2015-01-23 | ↗ |
| 23 | KKR European Fund II, Limited Partnership | — | 0.00% | — | — | — | 10.00 | PN | Cayman Islands | 2015-01-23 | ↗ |
| 24 | KKR Fund Holdings GP Limited | — | 0.00% | — | — | — | 10.00 | CO | Cayman Islands | 2015-01-23 | ↗ |
| 25 | KKR Fund Holdings L.P. | — | 0.00% | — | — | — | 10.00 | PN | Cayman Islands | 2015-01-23 | ↗ |
| 26 | KKR Group Holdings L.P. | — | 0.00% | — | — | — | 10.00 | PN | Cayman Islands | 2015-01-23 | ↗ |
| 27 | KKR Group Limited | — | 0.00% | — | — | — | 10.00 | CO | Cayman Islands | 2015-01-23 | ↗ |
| 28 | KKR Management LLC | — | 0.00% | — | — | — | 10.00 | OO | Delaware | 2015-01-23 | ↗ |
| 29 | KKR PEI Associates, L.P. | — | 0.00% | — | — | — | 10.00 | PN | Guernsey, Channel Islands | 2015-01-23 | ↗ |
| 30 | KKR PEI GP Limited | — | 0.00% | — | — | — | 10.00 | CO | Cayman Islands | 2015-01-23 | ↗ |
| 31 | KKR PEI Investments, L.P. | — | 0.00% | — | — | — | 10.00 | PN | Guernsey, Channel Islands | 2015-01-23 | ↗ |
| 32 | KKR Sprint Limited | — | 0.00% | — | — | — | 10.00 | CO | Cayman Islands | 2015-01-23 | ↗ |
| 33 | KKR Sprint (European II) Limited | — | 0.00% | — | — | — | 10.00 | CO | Cayman Islands | 2015-01-23 | ↗ |
| 34 | KKR Sprint (KPE) Limited | — | 0.00% | — | — | — | 10.00 | CO | Cayman Islands | 2015-01-23 | ↗ |
| 35 | NEWCIP S.A. | — | 0.00% | — | — | — | 10.00 | CO | Grand Duchy of Luxembourg | 2015-01-23 | ↗ |
| 36 | Stefano Pessina | — | 0.00% | — | — | — | 10.00 | IN | Monaco | 2015-01-23 | ↗ |
Institutional Activity (13F)
| # | Investor | Shares / Δ | Mkt value / Δ | Own% / Δ | Weight% / Δ | Avg px / Perf. | Hold / Status |
|---|---|---|---|---|---|---|---|
| 1 | VANGUARD GROUP INC | 23.62M +221.6K (+0.9%) | 7.98B +664.9M (+9.1%) | 12.16% +0.089 pp | 0.12% +0.006 pp | USD102.16 +230.6% | 84 qtrs — |
| 2 | BLACKROCK, INC. | 20.29M +508.6K (+2.6%) | 6.85B +670.6M (+10.8%) | 10.45% +0.241 pp | 0.12% +0.008 pp | USD239.30 +41.1% | 6 qtrs — |
| 3 | STATE STREET CORP | 9.31M +115.2K (+1.3%) | 3.14B +270.7M (+9.4%) | 4.79% +0.050 pp | 0.11% +0.006 pp | USD144.82 +133.2% | 41 qtrs — |
| 4 | PRICE T ROWE ASSOCIATES INC /MD/ | 6.99M -731.1K (-9.5%) | 2.36B -52.1M (-2.2%) | 3.60% -0.385 pp | 0.25% -0.004 pp | USD175.07 +92.9% | 75 qtrs — |
| 5 | T. ROWE PRICE INVESTMENT MANAGEMENT, INC. | 6.70M +4.1M (+160.1%) | 2.26B +1.5B (+181.1%) | 3.45% +2.121 pp | 1.43% +0.936 pp | USD324.85 +4.0% | 5 qtrs — |
| 6 | FMR LLC | 5.46M +2.1M (+64.9%) | 1.84B +809.1M (+78.2%) | 2.81% +1.103 pp | 0.09% +0.040 pp | USD267.12 +26.4% | 70 qtrs — |
| 7 | GEODE CAPITAL MANAGEMENT, LLC | 5.46M +169.1K (+3.2%) | 1.84B +196.1M (+11.9%) | 2.81% +0.081 pp | 0.11% +0.009 pp | USD151.06 +123.6% | 78 qtrs — |
| 8 | JPMORGAN CHASE & CO | 4.98M +304.8K (+6.5%) | 1.68B +220.9M (+15.1%) | 2.57% +0.152 pp | 0.11% +0.018 pp | USD161.43 +109.2% | 51 qtrs — |
| 9 | WELLINGTON MANAGEMENT GROUP LLP | 4.54M +564.9K (+14.2%) | 1.53B +290.9M (+23.4%) | 2.34% +0.287 pp | 0.27% +0.051 pp | USD220.00 +53.5% | 69 qtrs — |
| 10 | BOSTON PARTNERS | 4.20M -312.6K (-6.9%) | 1.42B +9.3M (+0.7%) | 2.16% -0.166 pp | 1.47% +0.022 pp | USD138.76 +143.4% | 29 qtrs — |
| 11 | INVESCO LTD. | 3.92M -90.5K (-2.3%) | 1.32B +70.5M (+5.6%) | 2.02% -0.051 pp | 0.20% +0.006 pp | USD191.04 +76.8% | 57 qtrs — |
| 12 | BANK OF AMERICA CORP /DE/ | 3.87M -93.4K (-2.4%) | 1.31B +68.4M (+5.5%) | 1.99% -0.052 pp | 0.10% +0.011 pp | USD220.76 +53.0% | 52 qtrs — |
| 13 | MORGAN STANLEY | 2.92M -415.9K (-12.4%) | 987.85M -56.2M (-5.4%) | 1.51% -0.218 pp | 0.06% -0.004 pp | USD171.41 +97.0% | 51 qtrs — |
| 14 | CAPITAL RESEARCH GLOBAL INVESTORS | 2.75M +88.5K (+3.3%) | 928.67M +97.0M (+11.7%) | 1.42% +0.043 pp | 0.17% +0.015 pp | USD182.69 +84.9% | 19 qtrs — |
| 15 | NORGES BANK | 2.44M +2.4M (+100.0%) | 822.51M +822.5M (+100.0%) | 1.25% +1.254 pp | 0.09% +0.088 pp | USD337.75 +0.0% | 1 qtrs NEW |
| 16 | AMUNDI | 2.23M +571.8K (+34.5%) | 753.30M +246.9M (+48.8%) | 1.15% +0.293 pp | 0.20% +0.042 pp | USD235.06 +43.7% | 19 qtrs — |
| 17 | NORTHERN TRUST CORP | 2.22M -48.7K (-2.1%) | 751.06M +40.8M (+5.8%) | 1.15% -0.028 pp | 0.10% +0.005 pp | USD110.12 +206.7% | 51 qtrs — |
| 18 | GOLDMAN SACHS GROUP INC | 2.13M +525.2K (+32.8%) | 718.76M +217.8M (+43.5%) | 1.10% +0.269 pp | 0.09% +0.027 pp | USD226.67 +49.0% | 73 qtrs — |
| 19 | UBS ASSET MANAGEMENT AMERICAS INC | 1.58M +106.0K (+7.2%) | 534.28M +73.0M (+15.8%) | 0.81% +0.053 pp | 0.11% +0.013 pp | USD294.95 +14.5% | 90 qtrs — |
| 20 | DIMENSIONAL FUND ADVISORS LP | 1.51M +38.3K (+2.6%) | 511.20M +50.2M (+10.9%) | 0.78% +0.018 pp | 0.11% +0.008 pp | USD137.48 +145.7% | 51 qtrs — |
| 21 | WELLS FARGO & COMPANY/MN | 1.38M +2.7K (+0.2%) | 466.07M +35.6M (+8.3%) | 0.71% 0.000 pp | 0.08% +0.003 pp | USD114.58 +194.8% | 57 qtrs — |
| 22 | BESSEMER GROUP INC | 1.37M -523.7K (-27.7%) | 461.05M -129.2M (-21.9%) | 0.70% -0.272 pp | 0.71% -0.195 pp | USD156.58 +115.7% | 39 qtrs — |
| 23 | LEGAL & GENERAL GROUP PLC | 1.35M -91.5K (-6.3%) | 456.05M +5.5M (+1.2%) | 0.70% -0.049 pp | 0.10% +0.000 pp | USD117.47 +187.5% | 75 qtrs — |
| 24 | ROYAL BANK OF CANADA | 1.33M +219.1K (+19.7%) | 449.04M +102.0M (+29.4%) | 0.68% +0.112 pp | 0.07% +0.016 pp | USD278.87 +21.1% | 51 qtrs — |
| 25 | NORDEA INVESTMENT MANAGEMENT AB | 1.26M +45.7K (+3.8%) | 426.72M +52.9M (+14.1%) | 0.65% +0.022 pp | 0.37% +0.039 pp | USD233.07 +44.9% | 83 qtrs — |
| 26 | ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | 1.25M +229.3K (+22.5%) | 421.50M +103.1M (+32.4%) | 0.64% +0.117 pp | 0.25% +0.046 pp | USD221.79 +52.3% | 26 qtrs — |
| 27 | CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 1.22M +11.6K (+1.0%) | 413.20M +34.5M (+9.1%) | 0.63% +0.005 pp | 0.06% +0.004 pp | USD143.78 +134.9% | 98 qtrs — |
| 28 | UBS GROUP AG | 1.12M +407.4K (+57.0%) | 379.20M +155.6M (+69.6%) | 0.58% +0.209 pp | 0.06% +0.027 pp | USD257.33 +31.3% | 45 qtrs — |
| 29 | ARTISAN PARTNERS LIMITED PARTNERSHIP | 1.12M -160.9K (-12.6%) | 377.83M -22.1M (-5.5%) | 0.58% -0.084 pp | 0.57% -0.002 pp | USD299.85 +12.6% | 3 qtrs — |
| 30 | BANK OF NEW YORK MELLON CORP | 1.05M -34.5K (-3.2%) | 355.62M +15.8M (+4.6%) | 0.54% -0.019 pp | 0.06% -0.003 pp | USD83.11 +306.4% | 66 qtrs — |
| 31 | RAYMOND JAMES FINANCIAL INC | 971.6K -95.7K (-9.0%) | 329.51M -4.1M (-1.2%) | 0.50% -0.050 pp | 0.10% -0.005 pp | USD224.68 +50.3% | 5 qtrs — |
| 32 | DEUTSCHE BANK AG\ | 920.8K -232.4K (-20.2%) | 310.99M -49.4M (-13.7%) | 0.47% -0.121 pp | 0.10% -0.020 pp | USD228.53 +47.8% | 50 qtrs — |
| 33 | MANUFACTURERS LIFE INSURANCE COMPANY, THE | 919.6K -248.2K (-21.3%) | 310.75M -54.2M (-14.9%) | 0.47% -0.129 pp | 0.26% -0.045 pp | USD228.11 +48.1% | 94 qtrs — |
| 34 | HOLOCENE ADVISORS, LP | 897.3K -204.6K (-18.6%) | 303.06M -41.3M (-12.0%) | 0.46% -0.107 pp | 0.64% -0.148 pp | USD274.39 +23.1% | 10 qtrs — |
| 35 | TD ASSET MANAGEMENT INC | 887.8K +569.3K (+178.7%) | 299.87M +200.3M (+201.2%) | 0.46% +0.293 pp | 0.24% +0.160 pp | USD267.52 +26.3% | 51 qtrs — |
| 36 | SUMITOMO MITSUI TRUST HOLDINGS, INC. | 877.9K -35.8K (-3.9%) | 296.51M +10.9M (+3.8%) | 0.45% -0.019 pp | 0.17% +0.010 pp | USD155.53 +117.2% | 59 qtrs — |
| 37 | CARMIGNAC GESTION | 875.1K -751.0 (-0.1%) | 295.57M +21.9M (+8.0%) | 0.45% -0.001 pp | 4.00% -0.082 pp | USD228.65 +47.7% | 7 qtrs — |
| 38 | ALLIANCEBERNSTEIN L.P. | 865.8K -24.0K (-2.7%) | 292.42M +14.3M (+5.2%) | 0.45% -0.013 pp | 0.09% +0.005 pp | USD172.04 +96.3% | 61 qtrs — |
| 39 | BANK OF MONTREAL /CAN/ | 857.6K +595.7K (+227.5%) | 289.66M +207.8M (+253.9%) | 0.44% +0.307 pp | 0.10% +0.069 pp | USD298.55 +13.1% | 51 qtrs — |
| 40 | NUVEEN, LLC | 804.6K +9.9K (+1.3%) | 271.75M +23.4M (+9.4%) | 0.41% +0.004 pp | 0.07% +0.006 pp | USD283.76 +19.0% | 4 qtrs — |
| 41 | NATIONAL PENSION SERVICE | 720.4K +42.7K (+6.3%) | 243.31M +31.5M (+14.9%) | 0.37% +0.021 pp | 0.18% +0.016 pp | USD225.62 +49.7% | 46 qtrs — |
| 42 | AMERICAN CENTURY COMPANIES INC | 697.2K -265.3K (-27.6%) | 235.47M -65.3M (-21.7%) | 0.36% -0.138 pp | 0.12% -0.035 pp | USD226.93 +48.8% | 25 qtrs — |
| 43 | NEUBERGER BERMAN GROUP LLC | 684.5K +7.3K (+1.1%) | 231.29M +19.9M (+9.4%) | 0.35% +0.003 pp | 0.17% +0.018 pp | USD150.55 +124.3% | 37 qtrs — |
| 44 | FEDERATED HERMES, INC. | 677.7K -100.2K (-12.9%) | 228.90M -14.2M (-5.9%) | 0.35% -0.052 pp | 0.38% -0.047 pp | USD243.66 +38.6% | 54 qtrs — |
| 45 | SWEDBANK AB | 672.5K -726.6K (-51.9%) | 227.15M -210.1M (-48.1%) | 0.35% -0.376 pp | 0.22% -0.224 pp | USD173.35 +94.8% | 20 qtrs — |
| 46 | AMERIPRISE FINANCIAL INC | 656.9K +7.0K (+1.1%) | 221.85M +18.7M (+9.2%) | 0.34% +0.003 pp | 0.05% +0.004 pp | USD268.76 +25.7% | 55 qtrs — |
| 47 | FIRST TRUST ADVISORS LP | 652.1K -61.4K (-8.6%) | 220.24M -2.8M (-1.2%) | 0.34% -0.032 pp | 0.16% -0.006 pp | USD143.14 +136.0% | 51 qtrs — |
| 48 | QUBE RESEARCH & TECHNOLOGIES LTD | 644.9K +33.5K (+5.5%) | 217.81M +26.7M (+14.0%) | 0.33% +0.017 pp | 0.22% +0.024 pp | USD250.41 +34.9% | 10 qtrs — |
| 49 | MAWER INVESTMENT MANAGEMENT LTD. | 618.3K -32.4K (-5.0%) | 208.83M +5.5M (+2.7%) | 0.32% -0.017 pp | 1.17% +0.114 pp | USD138.75 +143.4% | 36 qtrs — |
| 50 | AQR CAPITAL MANAGEMENT LLC | 576.4K -226.3K (-28.2%) | 194.67M -53.0M (-21.4%) | 0.30% -0.117 pp | 0.10% -0.057 pp | USD212.26 +59.1% | 27 qtrs — |
| 51 | CAISSE DE DEPOT ET PLACEMENT DU QUEBEC | 575.9K -307.6K (-34.8%) | 194.50M -81.6M (-29.6%) | 0.30% -0.159 pp | 0.33% -0.168 pp | USD263.74 +28.1% | 51 qtrs — |
| 52 | MASSACHUSETTS FINANCIAL SERVICES CO /MA/ | 568.1K -89.6K (-13.6%) | 191.88M -13.7M (-6.7%) | 0.29% -0.047 pp | 0.06% -0.002 pp | USD102.12 +230.7% | 51 qtrs — |
| 53 | PACER ADVISORS, INC. | 561.7K +541.5K (+2,682.3%) | 189.70M +183.4M (+2,906.8%) | 0.29% +0.279 pp | 0.48% +0.469 pp | USD336.35 +0.4% | 44 qtrs — |
| 54 | SEI INVESTMENTS CO | 506.9K -21.7K (-4.1%) | 171.20M +6.0M (+3.6%) | 0.26% -0.012 pp | 0.17% -0.009 pp | USD214.15 +57.7% | 45 qtrs — |
| 55 | SWISS NATIONAL BANK | 504.7K -26.0K (-4.9%) | 170.46M +4.6M (+2.8%) | 0.26% -0.014 pp | 0.10% +0.005 pp | USD120.11 +181.2% | 51 qtrs — |
| 56 | CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM | 494.7K -94.1K (-16.0%) | 167.08M -16.9M (-9.2%) | 0.25% -0.049 pp | 0.10% -0.015 pp | USD141.94 +138.0% | 58 qtrs — |
| 57 | ENVESTNET ASSET MANAGEMENT INC | 477.5K -47.6K (-9.1%) | 161.28M -2.8M (-1.7%) | 0.25% -0.025 pp | 0.05% +0.001 pp | USD161.82 +108.7% | 51 qtrs — |
| 58 | BNP PARIBAS ASSET MANAGEMENT HOLDING S.A. | 434.1K +253.7K (+140.6%) | 146.65M +90.8M (+162.6%) | 0.22% +0.130 pp | 0.17% +0.024 pp | USD293.33 +15.1% | 51 qtrs — |
| 59 | RHUMBLINE ADVISERS | 432.7K +2.5K (+0.6%) | 146.14M +11.7M (+8.7%) | 0.22% +0.001 pp | 0.12% +0.010 pp | USD112.63 +199.9% | 52 qtrs — |
| 60 | FRANKLIN RESOURCES INC | 432.5K -9.6K (-2.2%) | 146.09M +7.9M (+5.7%) | 0.22% -0.005 pp | 0.04% +0.001 pp | USD238.13 +41.8% | 51 qtrs — |
| 61 | TIMESSQUARE CAPITAL MANAGEMENT, LLC | 423.0K -20.6K (-4.6%) | 142.88M +4.2M (+3.1%) | 0.22% -0.011 pp | 2.15% +0.170 pp | USD112.08 +201.3% | 24 qtrs — |
| 62 | DEKABANK DEUTSCHE GIROZENTRALE | 543.0K +— (+0.0%) | 142.80M -23.1M (-13.9%) | 0.28% -0.001 pp | 0.25% -0.032 pp | USD161.92 +108.6% | 66 qtrs — |
| 63 | BNP PARIBAS ARBITRAGE, SNC | 403.3K -144.6K (-26.4%) | 136.21M -35.0M (-20.5%) | 0.21% -0.075 pp | 0.06% -0.030 pp | USD231.28 +46.0% | 51 qtrs — |
| 64 | MITSUBISHI UFJ KOKUSAI ASSET MANAGEMENT CO., LTD. | 400.6K +19.8K (+5.2%) | 135.75M +16.7M (+14.1%) | 0.21% +0.010 pp | 0.09% +0.006 pp | USD214.12 +57.7% | 58 qtrs — |
| 65 | JANUS HENDERSON GROUP PLC | 397.1K -3.7K (-0.9%) | 134.12M +8.9M (+7.1%) | 0.20% -0.002 pp | 0.06% +0.003 pp | USD187.28 +80.3% | 88 qtrs — |
| 66 | HSBC HOLDINGS PLC | 394.1K -73.7K (-15.8%) | 133.24M -12.9M (-8.8%) | 0.20% -0.039 pp | 0.07% -0.013 pp | USD200.45 +68.5% | 56 qtrs — |
| 67 | BARCLAYS PLC | 388.5K -105.2K (-21.3%) | 131.21M +20.1M (+18.1%) | 0.20% -0.055 pp | 0.03% +0.003 pp | USD186.24 +81.4% | 51 qtrs — |
| 68 | ALLSPRING GLOBAL INVESTMENTS HOLDINGS, LLC | 383.1K -40.6K (-9.6%) | 129.81M -2.3M (-1.7%) | 0.20% -0.021 pp | 0.21% -0.002 pp | USD276.04 +22.4% | 17 qtrs — |
| 69 | TRUIST FINANCIAL CORP | 378.7K -23.6K (-5.9%) | 127.91M +2.2M (+1.7%) | 0.20% -0.013 pp | 0.17% +0.001 pp | USD161.09 +109.7% | 51 qtrs — |
| 70 | MILLENNIUM MANAGEMENT LLC | 374.4K -611.5K (-62.0%) | 126.45M -181.7M (-59.0%) | 0.19% -0.316 pp | 0.05% -0.078 pp | USD249.13 +35.6% | 52 qtrs — |
| 71 | JOHNSON INVESTMENT COUNSEL INC | 369.0K -19.2K (-5.0%) | 124.64M +3.3M (+2.7%) | 0.19% -0.010 pp | 1.02% +0.005 pp | USD167.72 +101.4% | 51 qtrs — |
| 72 | SKANDINAVISKA ENSKILDA BANKEN AB (PUBL) | 367.1K +71.3K (+24.1%) | 123.99M +31.6M (+34.1%) | 0.19% +0.036 pp | 0.50% +0.126 pp | USD247.33 +36.6% | 40 qtrs — |
| 73 | D. E. SHAW & CO., INC. | 359.1K +128.8K (+55.9%) | 121.30M +49.3M (+68.5%) | 0.18% +0.066 pp | 0.07% +0.026 pp | USD289.71 +16.6% | 33 qtrs — |
| 74 | VOYA INVESTMENT MANAGEMENT LLC | 359.1K -14.4K (-3.8%) | 121.29M +4.6M (+3.9%) | 0.18% -0.008 pp | 0.12% +0.003 pp | USD207.98 +62.4% | 51 qtrs — |
| 75 | JANE STREET GROUP, LLC | 348.1K +7.7K (+2.3%) | 117.57M +11.2M (+10.5%) | 0.18% +0.004 pp | 0.02% +0.002 pp | USD228.28 +48.0% | 6 qtrs — |
| 76 | HANDELSBANKEN FONDER AB | 347.3K +7.5K (+2.2%) | 117.30M +11.1M (+10.4%) | 0.18% +0.004 pp | 0.35% +0.017 pp | USD143.57 +135.3% | 23 qtrs — |
| 77 | GREAT LAKES ADVISORS, LLC | 339.4K -3.0K (-0.9%) | 114.63M +7.6M (+7.1%) | 0.17% -0.002 pp | 0.93% +0.041 pp | USD185.58 +82.0% | 53 qtrs — |
| 78 | WORLDQUANT MILLENNIUM ADVISORS LLC | 331.6K +328.5K (+10,574.0%) | 112.01M +111.0M (+11,435.3%) | 0.17% +0.169 pp | 0.43% +0.430 pp | USD337.47 +0.1% | 10 qtrs — |
| 79 | SG AMERICAS SECURITIES, LLC | 319.5K +302.3K (+1,750.8%) | 107.93M +102.5M (+1,900.1%) | 0.16% +0.156 pp | 0.14% +0.120 pp | USD332.23 +1.7% | 51 qtrs — |
| 80 | WESTFIELD CAPITAL MANAGEMENT CO LP | 319.2K -6.4K (-2.0%) | 107.81M +6.0M (+5.9%) | 0.16% -0.004 pp | 0.45% +0.022 pp | USD284.11 +18.9% | 4 qtrs — |
| 81 | CITADEL ADVISORS LLC | 294.0K +25.4K (+9.5%) | 99.30M +15.4M (+18.3%) | 0.15% +0.013 pp | 0.01% +0.002 pp | USD196.05 +72.3% | 38 qtrs — |
| 82 | ZURCHER KANTONALBANK (ZURICH CANTONALBANK) | 289.4K +179.1K (+162.4%) | 97.73M +63.3M (+183.6%) | 0.15% +0.092 pp | 0.21% +0.132 pp | USD280.20 +20.5% | 57 qtrs — |
| 83 | CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM | 289.3K -10.0K (-3.3%) | 97.72M +4.2M (+4.5%) | 0.15% -0.006 pp | 0.10% +0.002 pp | USD99.51 +239.4% | 52 qtrs — |
| 84 | LPL FINANCIAL LLC | 289.0K +23.9K (+9.0%) | 97.60M +14.7M (+17.8%) | 0.15% +0.012 pp | 0.03% +0.003 pp | USD193.32 +74.7% | 37 qtrs — |
| 85 | WEALTH ENHANCEMENT ADVISORY SERVICES, LLC | 277.8K -2.1K (-0.8%) | 96.17M +9.8M (+11.3%) | 0.14% -0.001 pp | 0.13% 0.000 pp | USD185.16 +82.4% | 12 qtrs — |
| 86 | CORNERSTONE INVESTMENT PARTNERS, LLC | 283.9K -7.4K (-2.5%) | 95.90M +4.9M (+5.3%) | 0.15% -0.004 pp | 3.72% -0.086 pp | USD125.02 +170.2% | 23 qtrs — |
| 87 | DANSKE BANK A/S | 274.4K -31.6K (-10.3%) | 92.67M -2.9M (-3.1%) | 0.14% -0.017 pp | 0.22% -0.022 pp | USD266.58 +26.7% | 8 qtrs — |
| 88 | FIRST MANHATTAN CO. LLC. | 266.7K -7.7K (-2.8%) | 90.07M +4.3M (+5.0%) | 0.14% -0.004 pp | 0.24% +0.010 pp | USD115.89 +191.4% | 51 qtrs — |
| 89 | SUSQUEHANNA INTERNATIONAL GROUP, LLP | 265.6K +142.1K (+115.1%) | 89.71M +51.1M (+132.4%) | 0.14% +0.073 pp | 0.01% +0.006 pp | USD278.47 +21.3% | 51 qtrs — |
| 90 | CLARK CAPITAL MANAGEMENT GROUP, INC. | 253.6K +2.2K (+0.9%) | 85.67M +7.1M (+9.0%) | 0.13% +0.001 pp | 0.53% +0.034 pp | USD177.32 +90.5% | 14 qtrs — |
| 91 | PRINCIPAL FINANCIAL GROUP INC | 253.0K +4.8K (+1.9%) | 85.44M +7.9M (+10.2%) | 0.13% +0.002 pp | 0.04% +0.005 pp | USD141.81 +138.2% | 81 qtrs — |
| 92 | CIBC PRIVATE WEALTH GROUP, LLC | 251.9K -14.1K (-5.3%) | 85.07M +1.9M (+2.3%) | 0.13% -0.008 pp | 0.14% +0.002 pp | USD179.64 +88.0% | 48 qtrs — |
| 93 | GREAT WEST LIFE ASSURANCE CO /CAN/ | 251.7K -38.5K (-13.3%) | 85.06M -4.3M (-4.9%) | 0.13% -0.020 pp | 0.15% +0.020 pp | USD126.84 +166.3% | 52 qtrs — |
| 94 | FIL LTD | 247.6K +12.9K (+5.5%) | 83.63M +10.3M (+14.0%) | 0.13% +0.006 pp | 0.06% +0.005 pp | USD117.84 +186.6% | 36 qtrs — |
| 95 | ACADIAN ASSET MANAGEMENT LLC | 245.9K +12.1K (+5.2%) | 83.04M +10.0M (+13.7%) | 0.13% +0.006 pp | 0.14% +0.009 pp | USD294.56 +14.7% | 23 qtrs — |
| 96 | ASSENAGON ASSET MANAGEMENT S.A. | 243.5K -109.5K (-31.0%) | 82.25M -28.1M (-25.5%) | 0.13% -0.057 pp | 0.11% -0.038 pp | USD308.73 +9.4% | 37 qtrs — |
| 97 | THRIVENT FINANCIAL FOR LUTHERANS | 240.2K -5.0K (-2.1%) | 81.13M +4.5M (+5.8%) | 0.12% -0.003 pp | 0.14% -0.007 pp | USD261.01 +29.4% | 74 qtrs — |
| 98 | EARNEST PARTNERS LLC | 234.2K -899.0 (-0.4%) | 79.10M +5.6M (+7.7%) | 0.12% -0.001 pp | 0.34% +0.020 pp | USD129.26 +161.3% | 51 qtrs — |
Insider Activity
| Date | Person | Role | Transaction | A/D | Security | Shares | Price | Value | Owned after | D/I | Filing |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-05-01 | Tyler Lauren M | Director | A-Award | A | Common Stock | 99 | 304.00 | 30.1K | 3,809 | D | ↗ |
| 2026-05-01 | NALLY DENNIS M | Director | A-Award | A | Common Stock | 116 | 304.00 | 35.3K | 13,075 | D | ↗ |
| 2026-05-01 | Cooper Ellen | Director | A-Award | A | Common Stock | 99 | 304.00 | 30.1K | 796 | D | ↗ |
| 2026-04-01 | Krikorian Lazarus | Officer | A-Award | A | Restricted Stock Units | 3,936 | 0.00 | — | 3,936 | D | ↗ |
| 2026-03-11 | Cleary James F | Officer | F-InKind | D | Common Stock | 5,409 | 350.30 | 1.89M | 160,357 | D | ↗ |
| 2026-03-11 | Campbell Elizabeth S | Officer | F-InKind | D | Common Stock | 5,842 | 350.30 | 2.05M | 30,706 | D | ↗ |
| 2026-03-11 | Battaglia Silvana | Officer | F-InKind | D | Common Stock | 3,673 | 350.30 | 1.29M | 23,566 | D | ↗ |
| 2026-03-05 | Tyler Lauren M | Director | A-Award | A | Common Stock | 557 | 359.28 | 200.1K | 3,710 | D | ↗ |
| 2026-03-05 | Ryerkerk Lori | Director | A-Award | A | Common Stock | 557 | 359.28 | 200.1K | 1,073 | D | ↗ |
| 2026-03-05 | NALLY DENNIS M | Director | A-Award | A | Common Stock | 557 | 359.28 | 200.1K | 12,959 | D | ↗ |
| 2026-03-05 | Miller Redonda | Director | A-Award | A | Common Stock | 557 | 359.28 | 200.1K | 3,751 | D | ↗ |
| 2026-03-05 | Kim Lorence H. | Director | A-Award | A | Common Stock | 557 | 359.28 | 200.1K | 4,081 | D | ↗ |
| 2026-03-05 | GREENBERG LON R | Director | A-Award | A | Common Stock | 557 | 359.28 | 200.1K | 18,408 | D | ↗ |
| 2026-03-05 | DURCAN DERMOT MARK | Director | A-Award | A | Common Stock | 905 | 359.28 | 325.1K | 23,767 | D | ↗ |
| 2026-03-05 | Cooper Ellen | Director | A-Award | A | Common Stock | 557 | 359.28 | 200.1K | 697 | D | ↗ |
| 2026-03-05 | Clyburn Frank | Director | A-Award | A | Common Stock | 557 | 359.28 | 200.1K | 1,724 | D | ↗ |
| 2026-03-05 | Baumann Werner | Director | A-Award | A | Common Stock | 557 | 359.28 | 200.1K | 3,687 | D | ↗ |
| 2026-02-20 | Mauch Robert P. | Director / Officer | M-Exempt | A | Common Stock | 3,762 | 86.09 | 323.9K | 69,155 | D | ↗ |
| 2026-02-18 | Mauch Robert P. | Director / Officer | S-Sale | D | Common Stock | 1,333 | 359.46 | 479.2K | 65,393 | D | ↗ |
| 2026-01-30 | Tyler Lauren M | Director | A-Award | A | Common Stock | 84 | 359.22 | 30.2K | 3,153 | D | ↗ |
| 2026-01-30 | NALLY DENNIS M | Director | A-Award | A | Common Stock | 98 | 359.22 | 35.2K | 12,402 | D | ↗ |
| 2026-01-30 | Cooper Ellen | Director | A-Award | A | Common Stock | 69 | 359.22 | 24.8K | 74 | D | ↗ |
| 2026-01-20 | Mauch Robert P. | Director / Officer | S-Sale | D | Common Stock | 5,096 | 354.73 | 1.81M | 66,726 | D | ↗ |
| 2026-01-20 | Cooper Ellen | Director | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2025-12-31 | Campbell Elizabeth S | Officer | A-Award | A | Common Stock | 34 | 287.09 | 9.6K | 23,925 | D | ↗ |
| 2025-12-31 | Battaglia Silvana | Officer | A-Award | A | Common Stock | 27 | 287.09 | 7.9K | 18,824 | D | ↗ |
| 2025-12-19 | Campbell Elizabeth S | Officer | S-Sale | D | Common Stock | 3,351 | 342.10 | 1.15M | 23,891 | D | ↗ |
| 2025-12-19 | Battaglia Silvana | Officer | S-Sale | D | Common Stock | 1,677 | 345.00 | 578.6K | 18,796 | D | ↗ |
| 2025-12-18 | Mauch Robert P. | Director / Officer | M-Exempt | D | Non-qualified Stock Option (Right to Buy) | 3,763 | 86.09 | 324.0K | 7,525 | D | ↗ |
| 2025-12-17 | NALLY DENNIS M | Director | G-Gift | D | Common Stock | 1,173 | 0.00 | — | 12,304 | D | ↗ |
| 2025-12-17 | Mauch Robert P. | Director / Officer | G-Gift | D | Common Stock | 3,000 | 0.00 | — | 66,392 | D | ↗ |
| 2025-12-17 | Krikorian Lazarus | Officer | S-Sale | D | Common Stock | 4,031 | 343.24 | 1.38M | 17,154 | D | ↗ |
| 2025-12-17 | Cleary James F | Officer | M-Exempt | A | Common Stock | 45,154 | 86.09 | 3.89M | 180,095 | D | ↗ |
| 2025-12-15 | Mauch Robert P. | Director / Officer | M-Exempt | A | Common Stock | 638 | 0.00 | — | 70,030 | D | ↗ |
| 2025-12-15 | Krikorian Lazarus | Officer | F-InKind | D | Common Stock | 91 | 350.32 | 31.9K | 21,185 | D | ↗ |
| 2025-12-15 | Cleary James F | Officer | F-InKind | D | Common Stock | 199 | 350.32 | 69.7K | 134,941 | D | ↗ |
| 2025-11-20 | Verma Pawan | Officer | F-InKind | D | Common Stock | 1,010 | 362.07 | 365.7K | 5,148 | D | ↗ |
| 2025-11-20 | Mauch Robert P. | Director / Officer | M-Exempt | D | Restricted Stock Units | 5,790 | 0.00 | — | 13,158 | D | ↗ |
| 2025-11-20 | Krikorian Lazarus | Officer | F-InKind | D | Common Stock | 421 | 362.07 | 152.4K | 21,185 | D | ↗ |
| 2025-11-20 | Cleary James F | Officer | F-InKind | D | Common Stock | 824 | 362.07 | 298.3K | 134,941 | D | ↗ |
| 2025-11-20 | Campbell Elizabeth S | Officer | M-Exempt | D | Restricted Stock Units | 1,590 | 0.00 | — | 3,180 | D | ↗ |
| 2025-11-20 | Battaglia Silvana | Officer | M-Exempt | A | Common Stock | 932 | 0.00 | — | 20,879 | D | ↗ |
| 2025-11-18 | Mauch Robert P. | Director / Officer | M-Exempt | A | Common Stock | 3,763 | 86.09 | 324.0K | 70,842 | D | ↗ |
| 2025-11-13 | Mauch Robert P. | Director / Officer | A-Award | A | Common Stock | 42,944 | 0.00 | — | 85,756 | D | ↗ |
| 2025-11-13 | Krikorian Lazarus | Officer | A-Award | A | Common Stock | 2,434 | 0.00 | — | 21,642 | D | ↗ |
| 2025-11-13 | Cleary James F | Officer | A-Award | A | Common Stock | 30,062 | 0.00 | — | 147,790 | D | ↗ |
| 2025-11-13 | Campbell Elizabeth S | Officer | A-Award | A | Common Stock | 20,613 | 0.00 | — | 35,920 | D | ↗ |
| 2025-11-13 | Battaglia Silvana | Officer | F-InKind | D | Common Stock | 5,612 | 312.53 | 1.75M | 19,947 | D | ↗ |
| 2025-11-12 | Verma Pawan | Officer | A-Award | A | Restricted Stock Units | 3,963 | 0.00 | — | 3,963 | D | ↗ |
| 2025-11-12 | Mauch Robert P. | Director / Officer | A-Award | A | Restricted Stock Units | 15,960 | 0.00 | — | 15,960 | D | ↗ |
| 2025-11-12 | Krikorian Lazarus | Officer | A-Award | A | Restricted Stock Units | 2,271 | 0.00 | — | 2,271 | D | ↗ |
| 2025-11-12 | Cleary James F | Officer | A-Award | A | Restricted Stock Units | 4,733 | 0.00 | — | 4,733 | D | ↗ |
| 2025-11-12 | Campbell Elizabeth S | Officer | A-Award | A | Restricted Stock Units | 3,523 | 0.00 | — | 3,523 | D | ↗ |
| 2025-11-12 | Battaglia Silvana | Officer | A-Award | A | Restricted Stock Units | 2,202 | 0.00 | — | 2,202 | D | ↗ |
| 2025-11-07 | Mauch Robert P. | Director / Officer | M-Exempt | A | Common Stock | 4,065 | 0.00 | — | 44,485 | D | ↗ |
| 2025-11-07 | Krikorian Lazarus | Officer | M-Exempt | D | Restricted Stock Units | 1,398 | 0.00 | — | 1,398 | D | ↗ |
| 2025-11-07 | Cleary James F | Officer | M-Exempt | A | Common Stock | 2,951 | 0.00 | — | 117,244 | D | ↗ |
| 2025-11-07 | Campbell Elizabeth S | Officer | M-Exempt | D | Restricted Stock Units | 2,023 | 0.00 | — | 0 | D | ↗ |
| 2025-11-07 | Battaglia Silvana | Officer | F-InKind | D | Common Stock | 473 | 360.70 | 170.6K | 12,674 | D | ↗ |
| 2025-11-01 | Tyler Lauren M | Director | A-Award | A | Common Stock | 89 | 337.81 | 30.1K | 3,069 | D | ↗ |
| 2025-11-01 | NALLY DENNIS M | Director | A-Award | A | Common Stock | 104 | 337.81 | 35.1K | 13,477 | D | ↗ |
| 2025-11-01 | Baumann Werner | Director | A-Award | A | Common Stock | 108 | 337.81 | 36.5K | 3,130 | D | ↗ |
| 2025-10-31 | Verma Pawan | Officer | M-Exempt | D | Restricted Stock Units | 8,537 | 0.00 | — | 0 | D | ↗ |
| 2025-10-20 | Mauch Robert P. | Director / Officer | M-Exempt | A | Common Stock | 3,763 | 86.09 | 324.0K | 43,037 | D | ↗ |
| 2025-10-01 | Verma Pawan | Officer | — | — | Common Stock | 0 | 0.00 | — | 14 | D | ↗ |
| 2025-10-01 | Campbell Elizabeth S | Officer | S-Sale | D | Common Stock | 1,886 | 313.28 | 590.8K | 12,824 | D | ↗ |
| 2025-09-30 | Clyburn Frank | Director | — | — | Common Stock | 0 | 0.00 | — | 1,167 | D | ↗ |
| 2025-09-18 | Mauch Robert P. | Director / Officer | M-Exempt | A | Common Stock | 3,763 | 86.09 | 324.0K | 44,371 | D | ↗ |
| 2025-09-16 | COLLIS STEVEN H | Director / Officer | M-Exempt | A | Common Stock | 29,350 | 86.09 | 2.53M | 337,263 | D | ↗ |
| 2025-08-19 | COLLIS STEVEN H | Director / Officer | S-Sale | D | Common Stock | 14,579 | 289.98 | 4.23M | 307,913 | D | ↗ |
| 2025-08-18 | Mauch Robert P. | Director / Officer | M-Exempt | A | Common Stock | 3,225 | 86.09 | 277.6K | 45,576 | D | ↗ |
| 2025-08-01 | Tyler Lauren M | Director | A-Award | A | Common Stock | 105 | 288.35 | 30.3K | 2,980 | D | ↗ |
| 2025-08-01 | NALLY DENNIS M | Director | A-Award | A | Common Stock | 122 | 288.35 | 35.2K | 13,373 | D | ↗ |
| 2025-08-01 | Baumann Werner | Director | A-Award | A | Common Stock | 126 | 288.35 | 36.3K | 3,022 | D | ↗ |
| 2025-07-22 | COLLIS STEVEN H | Director / Officer | M-Exempt | A | Common Stock | 12,578 | 86.09 | 1.08M | 324,491 | D | ↗ |
| 2025-07-18 | Mauch Robert P. | Director / Officer | M-Exempt | A | Common Stock | 3,225 | 86.09 | 277.6K | 47,319 | D | ↗ |
| 2025-07-01 | Ryerkerk Lori | Director | A-Award | A | Common Stock | 516 | 0.00 | — | 516 | D | ↗ |
| 2025-06-30 | Campbell Elizabeth S | Officer | A-Award | A | Common Stock | 46 | 254.87 | 11.6K | 14,710 | D | ↗ |
| 2025-06-30 | Battaglia Silvana | Officer | A-Award | A | Common Stock | 53 | 254.87 | 13.4K | 11,349 | D | ↗ |
| 2025-06-24 | COLLIS STEVEN H | Director / Officer | M-Exempt | A | Common Stock | 12,579 | 86.09 | 1.08M | 326,492 | D | ↗ |
| 2025-06-18 | Mauch Robert P. | Director / Officer | M-Exempt | A | Common Stock | 3,225 | 86.09 | 277.6K | 49,063 | D | ↗ |
| 2025-06-18 | Battaglia Silvana | Officer | S-Sale | D | Common Stock | 4,077 | 297.41 | 1.21M | 11,297 | D | ↗ |
| 2025-06-01 | Ryerkerk Lori | Director | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2025-05-29 | Krikorian Lazarus | Officer | S-Sale | D | Common Stock | 2,992 | 288.96 | 864.6K | 17,162 | D | ↗ |
| 2025-05-20 | COLLIS STEVEN H | Director / Officer | M-Exempt | A | Common Stock | 12,578 | 86.09 | 1.08M | 328,491 | D | ↗ |
| 2025-05-19 | Mauch Robert P. | Director / Officer | S-Sale | D | Common Stock | 4,969 | 291.43 | 1.45M | 45,838 | D | ↗ |
| 2025-05-14 | GREENBERG LON R | Director | S-Sale | D | Common Stock | 3,000 | 279.05 | 837.2K | 17,851 | D | ↗ |
| 2025-05-01 | Tyler Lauren M | Director | A-Award | A | Common Stock | 104 | 290.43 | 30.2K | 2,875 | D | ↗ |
| 2025-05-01 | NALLY DENNIS M | Director | A-Award | A | Common Stock | 121 | 290.43 | 35.1K | 13,251 | D | ↗ |
| 2025-05-01 | Baumann Werner | Director | A-Award | A | Common Stock | 125 | 290.43 | 36.3K | 2,896 | D | ↗ |
| 2025-04-23 | Cleary James F | Officer | J-Other | D | Common Stock | 35,000 | 0.00 | — | 114,293 | D | ↗ |
| 2025-04-22 | COLLIS STEVEN H | Director / Officer | M-Exempt | A | Common Stock | 12,579 | 86.09 | 1.08M | 330,492 | D | ↗ |
| 2025-04-21 | Mauch Robert P. | Director / Officer | S-Sale | D | Common Stock | 4,969 | 289.33 | 1.44M | 47,582 | D | ↗ |
| 2025-03-25 | COLLIS STEVEN H | Director / Officer | S-Sale | D | Common Stock | 12,578 | 269.51 | 3.39M | 319,913 | D | ↗ |
| 2025-03-24 | Campbell Elizabeth S | Officer | S-Sale | D | Common Stock | 2,000 | 268.28 | 536.6K | 14,665 | D | ↗ |
| 2025-03-18 | Mauch Robert P. | Director / Officer | M-Exempt | A | Common Stock | 3,226 | 86.09 | 277.7K | 54,296 | D | ↗ |
| 2025-03-10 | Krikorian Lazarus | Officer | S-Sale | D | Common Stock | 2,000 | 260.06 | 520.1K | 20,154 | D | ↗ |
| 2025-03-06 | Tyler Lauren M | Director | A-Award | A | Common Stock | 789 | 0.00 | — | 2,771 | D | ↗ |
| 2025-03-06 | NALLY DENNIS M | Director | A-Award | A | Common Stock | 789 | 0.00 | — | 13,130 | D | ↗ |
| 2025-03-06 | Miller Redonda | Director | A-Award | A | Common Stock | 789 | 0.00 | — | 3,194 | D | ↗ |
| 2025-03-06 | Kim Lorence H. | Director | A-Award | A | Common Stock | 789 | 0.00 | — | 3,524 | D | ↗ |
| 2025-03-06 | GREENBERG LON R | Director | A-Award | A | Common Stock | 789 | 0.00 | — | 20,851 | D | ↗ |
| 2025-03-06 | DURCAN DERMOT MARK | Director | A-Award | A | Common Stock | 986 | 0.00 | — | 22,862 | D | ↗ |
| 2025-03-06 | Clyburn Frank | Director | A-Award | A | Common Stock | 789 | 0.00 | — | 1,157 | D | ↗ |
| 2025-03-06 | Baumann Werner | Director | A-Award | A | Common Stock | 789 | 0.00 | — | 2,771 | D | ↗ |
| 2025-03-03 | Mauch Robert P. | Director / Officer | M-Exempt | A | Common Stock | 3,226 | 86.09 | 277.7K | 54,296 | D | ↗ |
| 2025-02-27 | COLLIS STEVEN H | Director / Officer | M-Exempt | A | Common Stock | 12,579 | 86.09 | 1.08M | 332,492 | D | ↗ |
| 2025-02-21 | Battaglia Silvana | Officer | S-Sale | D | Common Stock | 5,000 | 242.24 | 1.21M | 15,374 | D | ↗ |
| 2025-02-06 | Walgreens Boots Alliance, Inc. | 10% Owner | J-Other | D | Common Stock | 447,775 | 244.51 | 109.49M | 12,774,491 | I | ↗ |
| 2025-01-31 | Tyler Lauren M | Director | A-Award | A | Common Stock | 99 | 254.21 | 25.2K | 1,982 | D | ↗ |
| 2025-01-31 | NALLY DENNIS M | Director | A-Award | A | Common Stock | 123 | 254.21 | 31.3K | 12,341 | D | ↗ |
| 2025-01-31 | Baumann Werner | Director | A-Award | A | Common Stock | 99 | 254.21 | 25.2K | 1,982 | D | ↗ |
| 2025-01-03 | Krikorian Lazarus | Officer | M-Exempt | A | Common Stock | 252 | 0.00 | — | 22,240 | D | ↗ |
| 2024-12-31 | Campbell Elizabeth S | Officer | A-Award | A | Common Stock | 53 | 190.98 | 10.2K | 18,792 | D | ↗ |
| 2024-12-31 | Battaglia Silvana | Officer | A-Award | A | Common Stock | 45 | 190.98 | 8.6K | 20,374 | D | ↗ |
| 2024-12-20 | Battaglia Silvana | Officer | S-Sale | D | Common Stock | 1,678 | 228.72 | 383.8K | 20,329 | D | ↗ |
| 2024-12-18 | Mauch Robert P. | Director / Officer | F-InKind | D | Common Stock | 789 | 232.24 | 183.2K | 52,814 | D | ↗ |
| 2024-12-18 | Krikorian Lazarus | Officer | M-Exempt | A | Common Stock | 108 | 0.00 | — | 22,096 | D | ↗ |
| 2024-12-18 | Cleary James F | Officer | M-Exempt | D | Restricted Stock Units | 207 | 0.00 | — | 6,043 | D | ↗ |
| 2024-12-18 | COLLIS STEVEN H | Director / Officer | M-Exempt | D | Restricted Stock Units | 395 | 0.00 | — | 9,474 | D | ↗ |
| 2024-12-03 | Krikorian Lazarus | Officer | S-Sale | D | Common Stock | 1,816 | 250.42 | 454.8K | 21,988 | D | ↗ |
| 2024-11-27 | Cleary James F | Officer | M-Exempt | A | Common Stock | 33,877 | 89.58 | 3.03M | 171,508 | D | ↗ |
| 2024-11-25 | COLLIS STEVEN H | Director / Officer | S-Sale | D | Common Stock | 50,000 | 243.98 | 12.20M | 326,557 | D | ↗ |
| 2024-11-21 | Mauch Robert P. | Director / Officer | F-InKind | D | Common Stock | 16,715 | 225.08 | 3.76M | 52,814 | D | ↗ |
| 2024-11-21 | Krikorian Lazarus | Officer | F-InKind | D | Common Stock | 792 | 225.08 | 178.3K | 23,804 | D | ↗ |
| 2024-11-21 | Cleary James F | Officer | F-InKind | D | Common Stock | 16,248 | 225.08 | 3.66M | 137,631 | D | ↗ |
| 2024-11-21 | Campbell Elizabeth S | Officer | F-InKind | D | Common Stock | 6,094 | 225.08 | 1.37M | 18,738 | D | ↗ |
| 2024-11-21 | COLLIS STEVEN H | Director / Officer | A-Award | A | Common Stock | 123,528 | 0.00 | — | 430,280 | D | ↗ |
| 2024-11-21 | Battaglia Silvana | Officer | F-InKind | D | Common Stock | 6,218 | 225.08 | 1.40M | 22,007 | D | ↗ |
| 2024-11-20 | Mauch Robert P. | Director / Officer | A-Award | A | Restricted Stock Units | 19,737 | 0.00 | — | 19,737 | D | ↗ |
| 2024-11-20 | Krikorian Lazarus | Officer | A-Award | A | Restricted Stock Units | 3,393 | 0.00 | — | 3,393 | D | ↗ |
| 2024-11-20 | Cleary James F | Officer | A-Award | A | Restricted Stock Units | 6,250 | 0.00 | — | 6,250 | D | ↗ |
| 2024-11-20 | Campbell Elizabeth S | Officer | A-Award | A | Restricted Stock Units | 4,770 | 0.00 | — | 4,770 | D | ↗ |
| 2024-11-20 | COLLIS STEVEN H | Director / Officer | A-Award | A | Restricted Stock Units | 9,869 | 0.00 | — | 9,869 | D | ↗ |
| 2024-11-20 | Battaglia Silvana | Officer | A-Award | A | Restricted Stock Units | 2,797 | 0.00 | — | 2,797 | D | ↗ |
| 2024-11-19 | COLLIS STEVEN H | Director / Officer | S-Sale | D | Common Stock | 21,509 | 242.16 | 5.21M | 306,752 | D | ↗ |
| 2024-11-08 | Mauch Robert P. | Director / Officer | M-Exempt | A | Common Stock | 4,215 | 0.00 | — | 30,725 | D | ↗ |
| 2024-11-08 | Krikorian Lazarus | Officer | M-Exempt | A | Common Stock | 1,061 | 0.00 | — | 21,103 | D | ↗ |
| 2024-11-08 | Cleary James F | Officer | M-Exempt | D | Restricted Stock Units | 3,395 | 0.00 | — | 0 | D | ↗ |
| 2024-11-08 | Campbell Elizabeth S | Officer | M-Exempt | A | Common Stock | 2,023 | 0.00 | — | 11,030 | D | ↗ |
| 2024-11-08 | COLLIS STEVEN H | Director / Officer | F-InKind | D | Common Stock | 3,067 | 248.41 | 761.9K | 306,752 | D | ↗ |
| 2024-11-08 | Battaglia Silvana | Officer | M-Exempt | A | Common Stock | 1,084 | 0.00 | — | 14,422 | D | ↗ |
| 2024-11-01 | Tyler Lauren M | Director | A-Award | A | Common Stock | 107 | 234.27 | 25.1K | 1,883 | D | ↗ |
| 2024-11-01 | NALLY DENNIS M | Director | A-Award | A | Common Stock | 134 | 234.27 | 31.4K | 12,218 | D | ↗ |
| 2024-11-01 | Clyburn Frank | Director | A-Award | A | Common Stock | 368 | 234.27 | 86.2K | 368 | D | ↗ |
| 2024-11-01 | Baumann Werner | Director | A-Award | A | Common Stock | 107 | 234.27 | 25.1K | 1,883 | D | ↗ |
| 2024-10-22 | COLLIS STEVEN H | Director / Officer | M-Exempt | A | Common Stock | 21,509 | 89.58 | 1.93M | 306,597 | D | ↗ |
| 2024-10-01 | Clyburn Frank | Director | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2024-09-17 | COLLIS STEVEN H | Director / Officer | S-Sale | D | Common Stock | 21,509 | 241.01 | 5.18M | 285,088 | — | ↗ |
| 2024-08-20 | COLLIS STEVEN H | Director / Officer | M-Exempt | D | Non-qualified Stock Option (Right to Buy) | 10,754 | 89.58 | 963.3K | 64,527 | — | ↗ |
| 2024-08-06 | Battaglia Silvana | Officer | S-Sale | D | Common Stock | 1,473 | 242.69 | 357.5K | 10,948 | — | ↗ |
| 2024-08-05 | GREENBERG LON R | Director | G-Gift | D | Common Stock | 5,000 | 0.00 | — | 20,062 | — | ↗ |
| 2024-08-01 | Walgreens Boots Alliance, Inc. | 10% Owner | S-Sale | D | Common Stock | 4,438,171 | 240.56 | 1.07B | 19,980,000 | — | ↗ |
| 2024-08-01 | Tyler Lauren M | Director | A-Award | A | Common Stock | 103 | 244.46 | 25.2K | 1,776 | — | ↗ |
| 2024-08-01 | NALLY DENNIS M | Director | A-Award | A | Common Stock | 128 | 244.46 | 31.3K | 12,084 | — | ↗ |
| 2024-08-01 | Baumann Werner | Director | A-Award | A | Common Stock | 103 | 244.46 | 25.2K | 1,776 | — | ↗ |
| 2024-07-16 | COLLIS STEVEN H | Director / Officer | M-Exempt | D | Non-qualified Stock Option (Right to Buy) | 10,755 | 89.58 | 963.4K | 75,281 | — | ↗ |
| 2024-07-01 | Donato Leslie E | Officer | M-Exempt | A | Common Stock | 1,432 | 0.00 | — | 9,991 | — | ↗ |
| 2024-06-28 | Donato Leslie E | Officer | A-Award | A | Common Stock | 67 | 191.51 | 12.8K | 9,525 | — | ↗ |
| 2024-06-28 | Campbell Elizabeth S | Officer | A-Award | A | Common Stock | 58 | 191.51 | 11.1K | 8,304 | — | ↗ |
| 2024-06-28 | Battaglia Silvana | Officer | A-Award | A | Common Stock | 66 | 191.51 | 12.7K | 12,421 | — | ↗ |
| 2024-06-18 | COLLIS STEVEN H | Director / Officer | M-Exempt | D | Non-qualified Stock Option (Right to Buy) | 10,754 | 89.58 | 963.3K | 86,036 | — | ↗ |
| 2024-05-31 | Clark Gina | Officer | S-Sale | D | Common Stock | 1,874 | 223.86 | 419.5K | 13,284 | — | ↗ |
| 2024-05-29 | Clark Gina | Officer | S-Sale | D | Common Stock | 27,093 | 216.07 | 5.85M | 15,158 | — | ↗ |
| 2024-05-24 | DURCAN DERMOT MARK | Director | P-Purchase | A | Common Stock | 500 | 218.58 | 109.3K | 21,876 | — | ↗ |
| 2024-05-22 | Walgreens Boots Alliance, Inc. | 10% Owner | S-Sale | D | Common Stock | 1,859,390 | 215.12 | 400.00M | 24,418,171 | — | ↗ |
| 2024-05-21 | COLLIS STEVEN H | Director / Officer | S-Sale | D | Common Stock | 10,755 | 221.30 | 2.38M | 285,088 | — | ↗ |
| 2024-05-01 | Tyler Lauren M | Director | A-Award | A | Common Stock | 110 | 229.20 | 25.2K | 1,673 | — | ↗ |
| 2024-05-01 | NALLY DENNIS M | Director | A-Award | A | Common Stock | 137 | 229.20 | 31.4K | 11,956 | — | ↗ |
| 2024-05-01 | Baumann Werner | Director | A-Award | A | Common Stock | 110 | 229.20 | 25.2K | 1,673 | — | ↗ |
| 2024-04-16 | COLLIS STEVEN H | Director / Officer | M-Exempt | D | Non-qualified Stock Option (Right to Buy) | 10,754 | 89.58 | 963.3K | 107,545 | — | ↗ |
| 2024-04-15 | Mauch Robert P. | Officer | M-Exempt | A | Common Stock | 33,877 | 89.58 | 3.03M | 81,976 | — | ↗ |
| 2024-03-19 | COLLIS STEVEN H | Director / Officer | M-Exempt | A | Common Stock | 10,755 | 89.58 | 963.4K | 295,843 | — | ↗ |
| 2024-03-18 | Clark Gina | Officer | S-Sale | D | Common Stock | 9,644 | 238.12 | 2.30M | 15,158 | — | ↗ |
| 2024-03-18 | Campbell Elizabeth S | Officer | S-Sale | D | Common Stock | 6,977 | 238.12 | 1.66M | 8,246 | — | ↗ |
| 2024-03-12 | Tyler Lauren M | Director | A-Award | A | Common Stock | 843 | 0.00 | — | 1,563 | — | ↗ |
| 2024-03-12 | NALLY DENNIS M | Director | A-Award | A | Common Stock | 843 | 0.00 | — | 11,819 | — | ↗ |
| 2024-03-12 | Miller Redonda | Director | A-Award | A | Common Stock | 843 | 0.00 | — | 2,405 | — | ↗ |
| 2024-03-12 | Kim Lorence H. | Director | A-Award | A | Common Stock | 843 | 0.00 | — | 2,735 | — | ↗ |
| 2024-03-12 | HYLE KATHLEEN W | Director | A-Award | A | Common Stock | 843 | 0.00 | — | 24,406 | — | ↗ |
| 2024-03-12 | GREENBERG LON R | Director | A-Award | A | Common Stock | 843 | 0.00 | — | 27,062 | — | ↗ |
| 2024-03-12 | GOCHNAUER RICHARD W | Director | A-Award | A | Common Stock | 843 | 0.00 | — | 28,762 | — | ↗ |
| 2024-03-12 | DURCAN DERMOT MARK | Director | A-Award | A | Common Stock | 1,053 | 0.00 | — | 21,376 | — | ↗ |
| 2024-03-12 | Baumann Werner | Director | A-Award | A | Common Stock | 843 | 0.00 | — | 1,563 | — | ↗ |
| 2024-03-11 | NALLY DENNIS M | Director | M-Exempt | D | Restricted Stock Units | 1,593 | 0.00 | — | 0 | — | ↗ |
| 2024-03-11 | HYLE KATHLEEN W | Director | M-Exempt | D | Restricted Stock Units | 1,593 | 0.00 | — | 0 | — | ↗ |
| 2024-03-11 | GOCHNAUER RICHARD W | Director | M-Exempt | D | Restricted Stock Units | 1,593 | 0.00 | — | 0 | — | ↗ |
| 2024-03-11 | DURCAN DERMOT MARK | Director | M-Exempt | D | Restricted Stock Units | 1,593 | 0.00 | — | 0 | — | ↗ |
| 2024-03-11 | Cleary James F | Officer | A-Award | A | Restricted Stock Units | 12,623 | 0.00 | — | 12,623 | — | ↗ |
| 2024-03-11 | Campbell Elizabeth S | Officer | A-Award | A | Restricted Stock Units | 12,623 | 0.00 | — | 12,623 | — | ↗ |
| 2024-03-11 | Battaglia Silvana | Officer | A-Award | A | Restricted Stock Units | 8,415 | 0.00 | — | 8,415 | — | ↗ |
| 2024-03-08 | Battaglia Silvana | Officer | M-Exempt | D | Restricted Stock Units | 1,211 | 0.00 | — | 0 | — | ↗ |
| 2024-02-13 | Clark Gina | Officer | S-Sale | D | Common Stock | 1,100 | 230.48 | 253.5K | 24,802 | — | ↗ |
| 2024-02-07 | Walgreens Boots Alliance, Inc. | 10% Owner | S-Sale | D | Common Stock | 4,212,395 | 235.41 | 991.64M | 26,277,561 | — | ↗ |
| 2024-02-01 | Tyler Lauren M | Director | A-Award | A | Common Stock | 106 | 0.00 | — | 720 | — | ↗ |
| 2024-02-01 | NALLY DENNIS M | Director | A-Award | A | Common Stock | 132 | 236.92 | 31.3K | 9,383 | — | ↗ |
| 2024-02-01 | Baumann Werner | Director | A-Award | A | Common Stock | 106 | 0.00 | — | 720 | — | ↗ |
| 2024-01-15 | GREENBERG LON R | Director | M-Exempt | A | Common Stock | 1,340 | 219.43 | 294.0K | 26,219 | — | ↗ |
| 2024-01-04 | Donato Leslie E | Officer | A-Award | A | Common Stock | 40 | 174.57 | 7.0K | 8,559 | — | ↗ |
| 2024-01-04 | Campbell Elizabeth S | Officer | A-Award | A | Common Stock | 58 | 174.57 | 10.0K | 15,223 | — | ↗ |
Executive team
Executive compensation
| # | Year | Executive | Salary | Bonus | Stock award | Option award | Incentive | Other | Total | % Stock- based |
Filing |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | 2025 | Robert P. Mauch President and Chief Executive Officer | 1.35M | — | 12.00M | — | 4.28M | 622.8K | 18.26M | 65.73% | ↗ |
| 2 | 2025 | Steven H. Collis Executive Chairman | 1.00M | — | 6.00M | — | 1.81M | 867.0K | 9.68M | 61.98% | ↗ |
| 3 | 2025 | James F. Cleary Executive Vice President and Chief Financial Officer | 926.1K | — | 3.80M | — | 1.68M | 116.5K | 6.52M | 58.27% | ↗ |
| 4 | 2025 | Elizabeth S. Campbell Executive Vice President and Chief Legal Officer | 769.2K | — | 2.90M | — | 1.39M | 112.7K | 5.18M | 56.02% | ↗ |
| 5 | 2025 | Silvana Battaglia Executive Vice President and Chief Human Resources Officer | 664.8K | — | 1.70M | — | 1.21M | 92.7K | 3.66M | 46.42% | ↗ |
| 6 | 2024 | Steven H. Collis Executive Chairman | 1.46M | — | 12.50M | — | 4.10M | 408.2K | 18.48M | 67.66% | ↗ |
| 7 | 2024 | Steven H. Collis Chairman, President and Chief Executive Officer | 1.46M | — | 12.50M | — | 4.10M | 408.2K | 18.48M | 67.66% | ↗ |
| 8 | 2024 | Robert P. Mauch President and Chief Executive Officer | 1.04M | — | 6.00M | — | 2.08M | 133.2K | 9.25M | 64.84% | ↗ |
| 9 | 2024 | Robert P. Mauch Executive Vice President and Chief Operating Officer | 1.04M | — | 6.00M | — | 2.08M | 133.2K | 9.25M | 64.84% | ↗ |
| 10 | 2024 | James F. Cleary Executive Vice President and Chief Financial Officer | 885.9K | — | 6.60M | — | 1.42M | 100.0K | 9.00M | 73.31% | ↗ |
| 11 | 2024 | Elizabeth S. Campbell Executive Vice President and Chief Legal Officer | 722.0K | — | 5.70M | — | 1.16M | 91.4K | 7.67M | 74.33% | ↗ |
| 12 | 2024 | Silvana Battaglia Executive Vice President and Chief Human Resources Officer | 626.0K | — | 3.60M | — | 1.00M | 92.3K | 5.32M | 67.67% | ↗ |
| 13 | 2023 | Steven H. Collis Chairman, President and Chief Executive Officer | 1.40M | — | 12.50M | — | 3.23M | 379.5K | 17.51M | 71.38% | ↗ |
| 14 | 2023 | Steven H. Collis Executive Chairman | 1.40M | — | 12.50M | — | 3.23M | 379.5K | 17.51M | 71.38% | ↗ |
| 15 | 2023 | Robert P. Mauch Executive Vice President and Chief Operating Officer | 975.0K | — | 5.00M | — | 1.61M | 115.1K | 7.70M | 64.96% | ↗ |
| 16 | 2023 | Robert P. Mauch President and Chief Executive Officer | 975.0K | — | 5.00M | — | 1.61M | 115.1K | 7.70M | 64.96% | ↗ |
| 17 | 2023 | James F. Cleary Executive Vice President and Chief Financial Officer | 795.0K | — | 3.50M | — | 1.05M | 105.5K | 5.45M | 64.23% | ↗ |
| 18 | 2023 | Elizabeth S. Campbell Executive Vice President and Chief Legal Officer | 670.0K | — | 2.40M | — | 883.7K | 73.4K | 4.03M | 59.60% | ↗ |
| 19 | 2023 | Gina K. Clark Executive Vice President and Chief Communications & Administration Officer | 640.0K | — | 1.60M | — | 844.2K | 85.9K | 3.17M | 50.47% | ↗ |
| 20 | 2023 | Silvana Battaglia Executive Vice President and Chief Human Resources Officer | 600.0K | — | 1.50M | — | 791.4K | 84.8K | 2.98M | 50.40% | ↗ |
| 21 | 2022 | Steven H. Collis Chairman, President and Chief Executive Officer | 1.40M | — | 11.25M | — | 3.22M | 870.3K | 16.74M | 67.22% | ↗ |
| 22 | 2022 | Robert P. Mauch Executive Vice President and Chief Operating Officer | 850.0K | — | 3.50M | — | 1.18M | 285.4K | 5.82M | 60.15% | ↗ |
| 23 | 2022 | James F. Cleary Executive Vice President and Chief Financial Officer | 770.0K | — | 3.20M | — | 1.07M | 279.9K | 5.32M | 60.13% | ↗ |
| 24 | 2022 | Silvana Battaglia Executive Vice President and Chief Human Resources Officer | 580.0K | — | 1.90M | — | 807.3K | 192.3K | 3.48M | 54.61% | ↗ |
| 25 | 2022 | Gina K. Clark Executive Vice President and Chief Communications & Administration Officer | 620.0K | — | 1.50M | — | 863.0K | 193.9K | 3.18M | 47.22% | ↗ |
| 26 | 2021 | Steven H. Collis Chairman, President and Chief Executive Officer | 1.40M | — | 10.50M | — | 2.25M | 724.5K | 14.87M | 70.60% | ↗ |
| 27 | 2021 | Robert P. Mauch Executive Vice President and Chief Operating Officer | 800.0K | — | 3.30M | — | 1.27M | 233.4K | 5.61M | 58.85% | ↗ |
| 28 | 2021 | Robert P. Mauch Executive Vice President and Group President | 800.0K | — | 3.30M | — | 1.27M | 233.4K | 5.61M | 58.85% | ↗ |
| 29 | 2021 | James F. Cleary Executive Vice President and Chief Financial Officer | 750.0K | — | 3.00M | — | 1.19M | 224.1K | 5.17M | 58.04% | ↗ |
| 30 | 2021 | John G. Chou Executive Vice President and Special Advisor to the Chairman & CEO (formerly the Chief Legal Officer) | 690.0K | — | 2.40M | — | 1.10M | 224.8K | 4.41M | 54.37% | ↗ |
| 31 | 2021 | Gina K. Clark Executive Vice President and Chief Communications & Administration Officer | 600.0K | — | 1.50M | — | 955.9K | 161.4K | 3.22M | 46.62% | ↗ |
| 32 | 2020 | Steven H. Collis Chairman, President and Chief Executive Officer | 1.33M | — | 6.83M | 2.93M | 2.53M | 692.1K | 14.30M | 68.21% | ↗ |
| 33 | 2020 | Paul E. Szurek President and Chief Executive Officer | 675.0K | — | 4.33M | — | 830.2K | 20.8K | 5.86M | 73.95% | ↗ |
| 34 | 2020 | Robert P. Mauch Executive Vice President and Chief Operating Officer | 700.0K | — | 1.75M | 750.0K | 890.4K | 219.2K | 4.31M | 58.01% | ↗ |
| 35 | 2020 | Robert P. Mauch Executive Vice President and Group President | 700.0K | — | 1.75M | 750.0K | 890.4K | 219.2K | 4.31M | 58.01% | ↗ |
| 36 | 2020 | James F. Cleary Executive Vice President and Chief Financial Officer | 700.0K | — | 1.75M | 750.0K | 890.4K | 192.5K | 4.28M | 58.37% | ↗ |
| 37 | 2020 | John G. Chou Executive Vice President and Special Advisor to the Chairman & CEO (formerly the Chief Legal Officer) | 675.0K | — | 1.61M | 690.0K | 858.6K | 215.1K | 4.05M | 56.81% | ↗ |
| 38 | 2020 | John G. Chou Executive Vice President and Chief Legal Officer | 675.0K | — | 1.61M | 690.0K | 858.6K | 215.1K | 4.05M | 56.81% | ↗ |
| 39 | 2020 | Gina K. Clark Executive Vice President and Chief Communications & Administration Officer | 575.0K | — | 1.05M | 450.0K | 731.4K | 149.2K | 2.96M | 50.75% | ↗ |
| 40 | 2020 | Steven J. Smith Chief Revenue Officer | 436.2K | — | 1.27M | — | 482.8K | 15.5K | 2.20M | 57.61% | ↗ |
| 41 | 2020 | Jeffrey S. Finnin Chief Financial Officer | 477.7K | — | 1.06M | — | 352.5K | 19.2K | 1.91M | 55.48% | ↗ |
| 42 | 2020 | Derek S. McCandless Senior Vice President, Legal, General Counsel and Secretary | 391.0K | — | 719.7K | — | 312.2K | 14.5K | 1.44M | 50.07% | ↗ |
| 43 | 2020 | Brian P. Warren Senior Vice President, Development and Product Engineering | 340.1K | — | 741.0K | — | 202.3K | 14.7K | 1.30M | 57.08% | ↗ |
| 44 | 2019 | Steven H. Collis Chairman, President and Chief Executive Officer | 1.24M | — | 5.60M | 2.40M | 1.87M | 202.9K | 11.31M | 70.74% | ↗ |
| 45 | 2019 | Steven H. Collis Chairman, President and CEO | 1.24M | — | 5.60M | 2.40M | 1.87M | 202.9K | 11.31M | 70.74% | ↗ |
| 46 | 2019 | Paul E. Szurek President and Chief Executive Officer | 650.0K | — | 4.26M | — | 460.4K | 17.5K | 5.39M | 79.05% | ↗ |
| 47 | 2019 | Robert P. Mauch Executive Vice President and Group President | 675.0K | — | 1.47M | 630.1K | 677.4K | 85.1K | 3.54M | 59.37% | ↗ |
| 48 | 2019 | John G. Chou Executive Vice President, Chief Legal Officer and Secretary | 660.0K | — | 1.47M | 630.1K | 662.3K | 86.2K | 3.51M | 59.86% | ↗ |
| 49 | 2019 | John G. Chou Executive Vice President and Chief Legal Officer | 660.0K | — | 1.47M | 630.1K | 662.3K | 86.2K | 3.51M | 59.86% | ↗ |
| 50 | 2019 | John G. Chou Executive Vice President and Special Advisor to the Chairman & CEO (formerly the Chief Legal Officer) | 660.0K | — | 1.47M | 630.1K | 662.3K | 86.2K | 3.51M | 59.86% | ↗ |
| 51 | 2019 | James F. Cleary Executive Vice President and CFO | 638.8K | — | 1.47M | 630.1K | 652.3K | 62.3K | 3.45M | 60.81% | ↗ |
| 52 | 2019 | James F. Cleary Executive Vice President and Chief Financial Officer | 638.8K | — | 1.47M | 630.1K | 652.3K | 62.3K | 3.45M | 60.81% | ↗ |
| 53 | 2019 | Gina K. Clark Executive Vice President and Chief Communications & Administration Officer | 500.0K | — | 910.0K | 390.1K | 501.8K | 64.4K | 2.37M | 54.94% | ↗ |
| 54 | 2019 | Steven J. Smith Chief Revenue Officer | 411.3K | — | 1.25M | — | 267.8K | 14.1K | 1.94M | 64.24% | ↗ |
| 55 | 2019 | Jeffrey S. Finnin Chief Financial Officer | 455.0K | — | 1.04M | — | 195.5K | 18.6K | 1.71M | 60.80% | ↗ |
| 56 | 2019 | Tim G. Guttman Former Executive Vice President and CFO | 710.0K | — | — | — | — | 657.5K | 1.37M | 0.00% | ↗ |
| 57 | 2019 | Derek S. McCandless Senior Vice President, Legal, General Counsel and Secretary | 362.0K | — | 674.5K | — | 155.6K | 16.2K | 1.21M | 55.82% | ↗ |
| 58 | 2019 | Brian P. Warren Senior Vice President, Development and Product Engineering | 312.5K | — | 700.5K | — | 108.8K | 14.1K | 1.14M | 61.67% | ↗ |
| 59 | 2018 | Steven H. Collis Chairman, President and Chief Executive Officer | 1.24M | — | 5.60M | 2.40M | 2.05M | 223.4K | 11.51M | 69.48% | ↗ |
| 60 | 2018 | Steven H. Collis Chairman, President and Executive Officer Chief | 1.24M | — | 5.60M | 2.40M | 2.05M | 223.4K | 11.51M | 69.48% | ↗ |
| 61 | 2018 | Steven H. Collis Chairman, President and CEO | 1.24M | — | 5.60M | 2.40M | 2.05M | 223.4K | 11.51M | 69.48% | ↗ |
| 62 | 2018 | Paul E. Szurek President and Chief Executive Officer | 632.5K | — | 4.18M | — | 875.9K | 14.7K | 5.71M | 73.31% | ↗ |
| 63 | 2018 | Tim G. Guttman Executive Vice President and Chief Financial Officer | 710.0K | — | 1.75M | 750.0K | 782.8K | 92.9K | 4.09M | 61.19% | ↗ |
| 64 | 2018 | Tim G. Guttman Former Executive Vice President and CFO | 710.0K | — | 1.75M | 750.0K | 782.8K | 92.9K | 4.09M | 61.19% | ↗ |
| 65 | 2018 | John G. Chou Executive Vice President, Chief Legal Officer and Secretary | 660.0K | — | 1.47M | 630.0K | 727.7K | 82.9K | 3.57M | 58.81% | ↗ |
| 66 | 2018 | John G. Chou Executive Vice President and Chief Legal Officer | 660.0K | — | 1.47M | 630.0K | 727.7K | 82.9K | 3.57M | 58.81% | ↗ |
| 67 | 2018 | John G. Chou Executive Vice President and Chief Legal & Business Officer | 660.0K | — | 1.47M | 630.0K | 727.7K | 82.9K | 3.57M | 58.81% | ↗ |
| 68 | 2018 | Robert P. Mauch Executive Vice President and Group President | 675.0K | — | 1.47M | 630.0K | 563.4K | 67.3K | 3.41M | 61.66% | ↗ |
| 69 | 2018 | Robert P. Mauch Executive Vice President and Group President, Pharmaceutical Distribution & Strategic Global | 675.0K | — | 1.47M | 630.0K | 563.4K | 67.3K | 3.41M | 61.66% | ↗ |
| 70 | 2018 | James F. Cleary Executive Vice President and CFO | 575.0K | — | 1.26M | 540.0K | 485.6K | 246.6K | 3.11M | 57.93% | ↗ |
| 71 | 2018 | James F. Cleary Executive Vice President and Chief Financial Officer | 575.0K | — | 1.26M | 540.0K | 485.6K | 246.6K | 3.11M | 57.93% | ↗ |
| 72 | 2018 | James F. Cleary, Jr. Executive Vice President and President, Global Commercialization Services & Animal Health | 575.0K | — | 1.26M | 540.0K | 485.6K | 246.6K | 3.11M | 57.93% | ↗ |
| 73 | 2018 | Steven J. Smith Chief Revenue Officer | 380.0K | — | 933.8K | — | 466.9K | 13.9K | 1.79M | 52.03% | ↗ |
| 74 | 2018 | Jeffrey S. Finnin Chief Financial Officer | 431.6K | — | 959.7K | — | 355.7K | 11.9K | 1.76M | 54.56% | ↗ |
| 75 | 2018 | Derek S. McCandless Senior Vice President, Legal, General Counsel and Secretary | 346.3K | — | 622.5K | — | 283.0K | 14.2K | 1.27M | 49.17% | ↗ |
| 76 | 2018 | Brian P. Warren Senior Vice President, Development and Product Engineering | 285.1K | — | 555.1K | — | 187.6K | 10.6K | 1.04M | 53.46% | ↗ |
| 77 | 2017 | Steven H. Collis Chairman, President and CEO | 1.24M | — | 4.20M | 2.80M | 1.34M | 327.4K | 9.91M | 70.65% | ↗ |
| 78 | 2017 | Steven H. Collis Chairman, President and Executive Officer Chief | 1.24M | — | 4.20M | 2.80M | 1.34M | 327.4K | 9.91M | 70.65% | ↗ |
| 79 | 2017 | Paul E. Szurek President and Chief Executive Officer | 580.0K | — | 2.62M | — | 843.2K | 36.7K | 4.08M | 64.24% | ↗ |
| 80 | 2017 | Tim G. Guttman Former Executive Vice President and CFO | 710.0K | — | 1.50M | 1.00M | 511.5K | 121.5K | 3.84M | 65.05% | ↗ |
| 81 | 2017 | Tim G. Guttman Executive Vice President and Chief Financial Officer | 710.0K | — | 1.50M | 1.00M | 511.5K | 121.5K | 3.84M | 65.05% | ↗ |
| 82 | 2017 | John G. Chou Executive Vice President and Chief Legal & Business Officer | 633.0K | — | 1.20M | 800.0K | 456.9K | 94.4K | 3.18M | 62.81% | ↗ |
| 83 | 2017 | John G. Chou Executive Vice President, Chief Legal Officer and Secretary | 633.0K | — | 1.20M | 800.0K | 456.9K | 94.4K | 3.18M | 62.81% | ↗ |
| 84 | 2017 | James D. Frary Former Executive Vice President and President, AmerisourceBergen Specialty Group | 600.0K | — | 1.08M | 720.0K | 631.6K | 112.4K | 3.14M | 57.25% | ↗ |
| 85 | 2017 | Robert P. Mauch Executive Vice President and Group President, Pharmaceutical Distribution & Strategic Global | 618.8K | — | 1.20M | 800.0K | 217.5K | 109.6K | 2.95M | 67.89% | ↗ |
| 86 | 2017 | Robert P. Mauch Executive Vice President and Group President, Pharmaceutical Distribution & Strategic Global Sourcing | 618.8K | — | 1.20M | 800.0K | 217.5K | 109.6K | 2.95M | 67.89% | ↗ |
| 87 | 2017 | Robert P. Mauch Executive Vice President and Group President | 618.8K | — | 1.20M | 800.0K | 217.5K | 109.6K | 2.95M | 67.89% | ↗ |
| 88 | 2017 | Peyton R. Howell Executive Vice President and President, Health Systems & Specialty Care Solutions | 533.8K | — | 900.0K | 600.0K | 385.9K | 96.4K | 2.52M | 59.62% | ↗ |
| 89 | 2017 | Steven J. Smith Chief Revenue Officer | 356.9K | — | 839.3K | — | 477.6K | 10.6K | 1.68M | 49.83% | ↗ |
| 90 | 2017 | Steven J. Smith Senior Vice President, Sales and Marketing | 356.9K | — | 839.3K | — | 477.6K | 10.6K | 1.68M | 49.83% | ↗ |
| 91 | 2017 | Jeffrey S. Finnin Chief Financial Officer | 413.3K | — | 891.8K | — | 366.4K | 11.9K | 1.68M | 52.98% | ↗ |
| 92 | 2017 | Derek S. McCandless Senior Vice President, Legal, General Counsel and Secretary | 329.6K | — | 577.0K | — | 268.1K | 10.6K | 1.19M | 48.68% | ↗ |
| 93 | 2017 | Brian P. Warren Senior Vice President, Engineering and Product | 268.3K | — | 524.6K | — | 176.1K | 10.5K | 979.4K | 53.56% | ↗ |
| 94 | 2017 | Brian P. Warren Senior Vice President, Development and Product Engineering | 268.3K | — | 524.6K | — | 176.1K | 10.5K | 979.4K | 53.56% | ↗ |
| 95 | 2016 | Steven H. Collis Chairman, President and Executive Officer Chief | 1.23M | — | 4.02M | 2.68M | 1.33M | 713.2K | 9.98M | 67.15% | ↗ |
| 96 | 2016 | Paul E. Szurek President and Chief Executive Officer | 246.1K | 250.0K | 3.32M | — | 242.7K | 56.4K | 4.12M | 80.69% | ↗ |
| 97 | 2016 | Thomas M. Ray Former President and Chief Executive Officer | 402.4K | — | 2.41M | — | 514.6K | 143.7K | 3.47M | 69.43% | ↗ |
| 98 | 2016 | Tim G. Guttman Executive Vice President and Chief Financial Officer | 706.5K | — | 1.20M | 800.0K | 508.0K | 153.9K | 3.37M | 59.37% | ↗ |
| 99 | 2016 | John G. Chou Executive Vice President and General Counsel | 621.2K | — | 1.20M | 800.0K | 446.5K | 123.1K | 3.19M | 62.68% | ↗ |
| 100 | 2016 | John G. Chou Executive Vice President and Chief Legal & Business Officer | 621.2K | — | 1.20M | 800.0K | 446.5K | 123.1K | 3.19M | 62.68% | ↗ |
| 101 | 2016 | James D. Frary Former Executive Vice President and President, AmerisourceBergen Specialty Group | 597.7K | — | 960.0K | 640.0K | 760.0K | 130.7K | 3.09M | 51.81% | ↗ |
| 102 | 2016 | James D. Frary Executive Vice President and President, AmerisourceBergen Specialty Group | 597.7K | — | 960.0K | 640.0K | 760.0K | 130.7K | 3.09M | 51.81% | ↗ |
| 103 | 2016 | Robert P. Mauch Executive Vice President and Group President, Pharmaceutical Distribution & Strategic Global Sourcing | 593.1K | — | 1.08M | 720.0K | 307.1K | 74.6K | 2.77M | 64.87% | ↗ |
| 104 | 2016 | Robert P. Mauch Executive Vice President and Group President, Pharmaceutical Distribution & Strategic Global | 593.1K | — | 1.08M | 720.0K | 307.1K | 74.6K | 2.77M | 64.87% | ↗ |
| 105 | 2016 | Robert P. Mauch Executive Vice President and President, AmerisourceBergen Drug Corporation | 593.1K | — | 1.08M | 720.0K | 307.1K | 74.6K | 2.77M | 64.87% | ↗ |
| 106 | 2016 | Steven J. Smith Senior Vice President, Sales and Marketing | 329.6K | — | 821.2K | — | 629.5K | 10.6K | 1.79M | 45.85% | ↗ |
| 107 | 2016 | Steven J. Smith Chief Revenue Officer | 329.6K | — | 821.2K | — | 629.5K | 10.6K | 1.79M | 45.85% | ↗ |
| 108 | 2016 | Jeffrey S. Finnin Chief Financial Officer | 392.3K | — | 657.0K | — | 367.4K | 11.9K | 1.43M | 45.99% | ↗ |
| 109 | 2016 | Derek S. McCandless Senior Vice President, Legal, General Counsel and Secretary | 309.6K | — | 547.5K | — | 320.6K | 10.6K | 1.12M | 48.96% | ↗ |
| 110 | 2016 | Brian P. Warren Senior Vice President, Development and Product Engineering | 244.6K | — | 438.0K | — | 214.7K | 10.0K | 907.3K | 48.27% | ↗ |
| 111 | 2016 | Brian P. Warren Senior Vice President, Engineering and Product | 244.6K | — | 438.0K | — | 214.7K | 10.0K | 907.3K | 48.27% | ↗ |
| 112 | 2015 | Steven H. Collis Chairman, President and Executive Officer Chief | 1.19M | — | 4.02M | 2.68M | 2.45M | 463.5K | 10.80M | 62.03% | ↗ |
| 113 | 2015 | Steven H. Collis President and Chief Executive Officer | 1.19M | — | 4.02M | 2.68M | 2.45M | 463.5K | 10.80M | 62.03% | ↗ |
| 114 | 2015 | Thomas M. Ray President and Chief Executive Officer | 543.3K | — | 2.43M | — | 877.3K | 11.9K | 3.86M | 62.89% | ↗ |
| 115 | 2015 | Thomas M. Ray Former President and Chief Executive Officer | 543.3K | — | 2.43M | — | 877.3K | 11.9K | 3.86M | 62.89% | ↗ |
| 116 | 2015 | Tim G. Guttman Executive Vice President and Chief Financial Officer | 676.5K | — | 1.20M | 800.0K | 1.04M | 133.2K | 3.85M | 52.01% | ↗ |
| 117 | 2015 | David W. Neu Executive Vice President and President, Good Neighbor | 630.0K | — | 1.02M | 683.2K | 802.8K | 287.1K | 3.43M | 49.83% | ↗ |
| 118 | 2015 | James D. Frary Former Executive Vice President and President, AmerisourceBergen Specialty Group | 574.2K | — | 900.1K | 600.0K | 972.7K | 104.6K | 3.15M | 47.60% | ↗ |
| 119 | 2015 | James D. Frary Executive Vice President and President, AmerisourceBergen Specialty Group | 574.2K | — | 900.1K | 600.0K | 972.7K | 104.6K | 3.15M | 47.60% | ↗ |
| 120 | 2015 | John G. Chou Executive Vice President and General Counsel | 600.0K | — | 780.0K | 520.0K | 914.0K | 113.8K | 2.93M | 44.40% | ↗ |
| 121 | 2015 | John G. Chou Executive Vice President and Chief Legal & Business Officer | 600.0K | — | 780.0K | 520.0K | 914.0K | 113.8K | 2.93M | 44.40% | ↗ |
| 122 | 2015 | Steven J. Smith Senior Vice President, Sales and Marketing | 311.0K | — | 551.7K | — | 685.0K | 10.5K | 1.56M | 35.41% | ↗ |
| 123 | 2015 | Jeffrey S. Finnin Chief Financial Officer | 382.3K | — | 662.1K | — | 250.0K | 11.9K | 1.31M | 50.68% | ↗ |
| 124 | 2015 | Derek S. McCandless Senior Vice President, Legal, General Counsel and Secretary | 291.6K | — | 551.7K | — | 250.0K | 10.4K | 1.10M | 49.98% | ↗ |
| 125 | 2015 | Brian P. Warren Senior Vice President, Engineering and Product | 226.0K | — | 331.1K | — | 220.0K | 9.3K | 786.4K | 42.10% | ↗ |
| 126 | 2014 | Steven H. Collis President and Chief Executive Officer | 1.19M | — | 4.02M | 2.68M | 1.86M | 157.3K | 9.90M | 67.66% | ↗ |
| 127 | 2014 | Steven H. Collis President and Chief Executive Officer | 1.19M | — | 4.02M | 2.68M | 1.86M | 157.3K | 9.90M | 67.66% | ↗ |
| 128 | 2014 | Steven H. Collis Chairman, President and Executive Officer Chief | 1.19M | — | 4.02M | 2.68M | 1.86M | 157.3K | 9.90M | 67.66% | ↗ |
| 129 | 2014 | David W. Neu Executive Vice President and President, Good Neighbor | 626.5K | — | 1.02M | 680.0K | 767.7K | 327.4K | 3.42M | 49.68% | ↗ |
| 130 | 2014 | David W. Neu Executive Vice President and President, AmerisourceBergen | 626.5K | — | 1.02M | 680.0K | 767.7K | 69.3K | 3.42M | 49.68% | ↗ |
| 131 | 2014 | Thomas M. Ray Former President and Chief Executive Officer | 510.0K | — | 2.04M | — | 693.0K | 11.7K | 3.25M | 62.66% | ↗ |
| 132 | 2014 | Thomas M. Ray President and Chief Executive Officer | 510.0K | — | 2.04M | — | 693.0K | 11.7K | 3.25M | 62.66% | ↗ |
| 133 | 2014 | Tim G. Guttman Executive Vice President and Chief Financial Officer | 632.7K | — | 1.02M | 680.0K | 752.4K | 56.0K | 3.14M | 54.12% | ↗ |
| 134 | 2014 | Tim G. Guttman Executive Vice President and Chief Financial Officer | 632.7K | — | 1.02M | 680.0K | 752.4K | 56.0K | 3.14M | 54.12% | ↗ |
| 135 | 2014 | James D. Frary Executive Vice President and President, AmerisourceBergen Specialty Group | 515.0K | — | 780.0K | 520.0K | 581.6K | 52.7K | 2.45M | 53.07% | ↗ |
| 136 | 2014 | James D. Frary Executive Vice President and President, AmerisourceBergen | 515.0K | — | 780.0K | 520.0K | 581.6K | 52.7K | 2.45M | 53.07% | ↗ |
| 137 | 2014 | John G. Chou Executive Vice President and General Counsel | 584.1K | — | 660.0K | 440.0K | 694.6K | 61.7K | 2.44M | 45.07% | ↗ |
| 138 | 2014 | John G. Chou Executive Vice President and General Counsel | 584.1K | — | 660.0K | 440.0K | 694.6K | 61.7K | 2.44M | 45.07% | ↗ |
| 139 | 2014 | Steven J. Smith Senior Vice President, Sales and Marketing | 276.9K | 150.0K | 577.9K | — | 568.6K | 6.0K | 1.58M | 36.59% | ↗ |
| 140 | 2014 | Jeffrey S. Finnin Chief Financial Officer | 372.5K | — | 555.8K | — | 250.0K | 11.7K | 1.19M | 46.71% | ↗ |
| 141 | 2014 | Derek S. McCandless Senior Vice President, Legal, General Counsel and Secretary | 278.8K | — | 463.2K | — | 190.0K | 10.4K | 942.4K | 49.15% | ↗ |
| 142 | 2013 | Steven H. Collis President and Chief Executive Officer | 1.16M | — | 7.71M | 1.68M | 1.31M | 144.0K | 12.00M | 78.22% | ↗ |
| 143 | 2013 | Steven H. Collis President and Chief Executive Officer | 1.16M | — | 7.71M | 1.68M | 1.31M | 144.0K | 12.00M | 78.22% | ↗ |
| 144 | 2013 | David W. Neu Executive Vice President and President, AmerisourceBergen | 600.0K | — | 780.0K | 520.0K | 512.9K | 61.7K | 2.47M | 52.53% | ↗ |
| 145 | 2013 | David W. Neu Executive Vice President and President, Good Neighbor | 600.0K | — | 780.0K | 520.0K | 512.9K | 61.7K | 2.47M | 52.53% | ↗ |
| 146 | 2013 | David W. Neu Senior Vice President and President, AmerisourceBergen | 600.0K | — | 780.0K | 520.0K | 512.9K | 61.7K | 2.47M | 52.53% | ↗ |
| 147 | 2013 | Thomas M. Ray President and Chief Executive Officer | 459.3K | — | 900.0K | 600.0K | 400.0K | 11.0K | 2.37M | 63.28% | ↗ |
| 148 | 2013 | Tim G. Guttman Senior Vice President and | 500.0K | — | 720.0K | 480.0K | 437.9K | 46.1K | 2.18M | 54.95% | ↗ |
| 149 | 2013 | Tim G. Guttman Executive Vice President and Chief Financial Officer | 500.0K | — | 720.0K | 480.0K | 437.9K | 46.1K | 2.18M | 54.95% | ↗ |
| 150 | 2013 | Tim G. Guttman Executive Vice President and Chief Financial Officer | 500.0K | — | 720.0K | 480.0K | 437.9K | 46.1K | 2.18M | 54.95% | ↗ |
| 151 | 2013 | John G. Chou Executive Vice President and General Counsel | 462.0K | — | 540.0K | 360.0K | 395.4K | 58.6K | 1.82M | 49.56% | ↗ |
| 152 | 2013 | John G. Chou Executive Vice President and General Counsel | 462.0K | — | 540.0K | 360.0K | 395.4K | 58.6K | 1.82M | 49.56% | ↗ |
| 153 | 2013 | James D. Frary Senior Vice President and President, AmerisourceBergen | 400.0K | — | 540.0K | 360.0K | 300.1K | 54.9K | 1.65M | 54.38% | ↗ |
| 154 | 2013 | James D. Frary Executive Vice President and President, AmerisourceBergen Specialty Group | 400.0K | — | 540.0K | 360.0K | 300.1K | 54.9K | 1.65M | 54.38% | ↗ |
| 155 | 2013 | James D. Frary Executive Vice President and President, AmerisourceBergen | 400.0K | — | 540.0K | 360.0K | 300.1K | 54.9K | 1.65M | 54.38% | ↗ |
| 156 | 2013 | Jeffrey S. Finnin Chief Financial Officer | 362.5K | — | 330.0K | 220.0K | 216.8K | 11.0K | 1.14M | 48.23% | ↗ |
| 157 | 2013 | Derek S. McCandless Senior Vice President, Legal, General Counsel and Secretary | 265.9K | — | 288.0K | 192.0K | 146.5K | 10.0K | 902.4K | 53.19% | ↗ |
| 158 | 2012 | Steven H. Collis President and Chief Executive Officer | 1.09M | — | 2.70M | 1.80M | 1.35M | 115.0K | 7.06M | 63.77% | ↗ |
| 159 | 2012 | David W. Neu Executive Vice President and President, AmerisourceBergen | 538.5K | — | 510.0K | 340.0K | 441.3K | 53.8K | 2.14M | 39.73% | ↗ |
| 160 | 2012 | David W. Neu Senior Vice President and President, AmerisourceBergen | 538.5K | — | 510.0K | 340.0K | 441.3K | 53.8K | 2.14M | 39.73% | ↗ |
| 161 | 2012 | John G. Chou Executive Vice President and General Counsel | 436.2K | — | 465.0K | 310.0K | 449.4K | 51.5K | 1.71M | 45.27% | ↗ |
| 162 | 2012 | James D. Frary Senior Vice President and President, AmerisourceBergen | 375.4K | — | 375.0K | 250.0K | 492.5K | 49.8K | 1.54M | 40.51% | ↗ |
| 163 | 2012 | James D. Frary Executive Vice President and President, AmerisourceBergen | 375.4K | — | 375.0K | 250.0K | 492.5K | 49.8K | 1.54M | 40.51% | ↗ |
| 164 | 2012 | Tim G. Guttman Executive Vice President and Chief Financial Officer | 363.2K | — | 180.2K | 334.8K | 325.0K | 23.8K | 1.23M | 41.97% | ↗ |
| 165 | 2012 | Tim G. Guttman Senior Vice President and | 363.2K | — | 180.2K | 334.8K | 325.0K | 23.8K | 1.23M | 41.97% | ↗ |
| 166 | 2011 | Steven H. Collis President and Chief Executive Officer | 834.6K | — | 727.4K | 1.33M | 1.08M | 637.1K | 4.61M | 44.56% | ↗ |
| 167 | 2011 | R. David Yost Retired Chief Executive Officer | 1.03M | — | — | — | 1.78M | 180.5K | 4.41M | 0.00% | ↗ |
| 168 | 2011 | Michael D. DiCandilo Executive Vice President and Chief Financial Officer | 709.4K | — | 666.8K | 1.22M | 883.7K | 97.6K | 3.91M | 48.15% | ↗ |
| 169 | 2011 | John G. Chou Executive Vice President and General Counsel | 373.7K | — | 257.6K | 469.8K | 454.0K | 51.9K | 1.61M | 45.27% | ↗ |
| 170 | 2011 | John G. Chou Executive Vice President, General Counsel and Secretary | 373.7K | — | 257.6K | 469.8K | 454.0K | 51.9K | 1.61M | 45.27% | ↗ |
| 171 | 2011 | David W. Neu Senior Vice President and President, AmerisourceBergen | 412.8K | — | 212.1K | 386.9K | 441.0K | 50.9K | 1.59M | 37.72% | ↗ |
| 172 | 2011 | David W. Neu Senior Vice President and President, AmerisourceBergen | 412.8K | — | 212.1K | 386.9K | 441.0K | 50.9K | 1.59M | 37.72% | ↗ |
| 173 | 2011 | Peyton R. Howell | 391.8K | — | 181.9K | 331.7K | 514.6K | 57.9K | 1.48M | 34.61% | ↗ |
| 174 | 2011 | James D. Frary Senior Vice President and President, AmerisourceBergen | 315.0K | — | 212.1K | 386.9K | 502.5K | 46.4K | 1.46M | 40.95% | ↗ |
| 175 | 2010 | R. David Yost Chief Executive Officer | 1.26M | — | 583.3K | 1.08M | 3.52M | 155.5K | 7.43M | 22.36% | ↗ |
| 176 | 2010 | R. David Yost Retired Chief Executive Officer | 1.26M | — | 583.3K | 1.08M | 3.52M | 155.5K | 7.43M | 22.36% | ↗ |
| 177 | 2010 | Steven H. Collis President and Chief Operating Officer | 652.0K | — | 536.7K | 991.9K | 1.08M | 1.28M | 4.66M | 32.79% | ↗ |
| 178 | 2010 | Steven H. Collis President and Chief Executive Officer | 652.0K | — | 536.7K | 991.9K | 1.08M | 1.28M | 4.66M | 32.79% | ↗ |
| 179 | 2010 | Michael D. DiCandilo Executive Vice President and Chief Financial Officer | 673.1K | — | 536.7K | 991.9K | 1.04M | 81.7K | 3.47M | 44.07% | ↗ |
| 180 | 2010 | James D. Frary Senior Vice President, AmerisourceBergen Corporation, and President, AmerisourceBergen Specialty Distribution and Services | 269.4K | — | 203.2K | — | 408.3K | 259.9K | 1.54M | 13.20% | ↗ |
| 181 | 2010 | John G. Chou Senior Vice President, General Counsel and Secretary | 330.5K | — | 198.3K | 366.6K | 509.0K | 41.2K | 1.45M | 38.90% | ↗ |
| 182 | 2010 | John G. Chou Executive Vice President, General Counsel and Secretary | 330.5K | — | 198.3K | 366.6K | 509.0K | 41.2K | 1.45M | 38.90% | ↗ |
| 183 | 2009 | R. David Yost President and Chief Executive Officer | 1.23M | — | 790.4K | 1.14M | 3.03M | 133.7K | 7.64M | 25.33% | ↗ |
| 184 | 2009 | R. David Yost Retired Chief Executive Officer | 1.23M | — | 370.3K | — | 3.03M | 133.7K | 6.85M | 5.40% | ↗ |
| 185 | 2009 | R. David Yost Chief Executive Officer | 1.23M | — | 370.3K | 778.1K | 3.03M | 133.7K | 6.85M | 16.76% | ↗ |
| 186 | 2009 | Michael D. DiCandilo Executive Vice President and Chief Financial Officer | 651.4K | — | 325.9K | 684.8K | 775.9K | 70.2K | 2.72M | 37.14% | ↗ |
| 187 | 2009 | Steven H. Collis Executive Vice President, AmerisourceBergen Corporation, and President, AmerisourceBergen Drug Corporation | 572.7K | — | 377.1K | — | 720.1K | 75.5K | 2.64M | 14.26% | ↗ |
| 188 | 2009 | Steven H. Collis President and Chief Operating Officer | 572.7K | — | 311.1K | 653.6K | 720.1K | 75.5K | 2.38M | 40.59% | ↗ |
| 189 | 2009 | Steven H. Collis President and Chief Executive Officer | 572.7K | — | 311.1K | 653.6K | 720.1K | 75.5K | 2.38M | 40.59% | ↗ |
| 190 | 2009 | Jeanne B. Fisher Senior Vice President, Human Resources | 330.5K | — | 212.1K | — | 373.3K | 40.1K | 1.25M | 16.93% | ↗ |
| 191 | 2009 | John G. Chou Senior Vice President, General Counsel and Secretary | 310.2K | — | 94.8K | 199.2K | 298.6K | 34.8K | 940.9K | 31.25% | ↗ |
| 192 | 2009 | John G. Chou Executive Vice President, General Counsel and Secretary | 310.2K | — | 94.8K | 199.2K | 298.6K | 34.8K | 940.9K | 31.25% | ↗ |
| 193 | 2008 | R. David Yost President and Chief Executive Officer | 1.18M | — | 459.8K | 1.14M | 2.72M | 129.4K | 5.71M | 27.96% | ↗ |
| 194 | 2008 | R. David Yost Chief Executive Officer | 1.18M | — | 447.1K | — | 2.72M | 129.4K | 5.48M | 8.16% | ↗ |
| 195 | 2008 | Michael D. DiCandilo Executive Vice President and Chief Financial Officer, AmerisourceBergen Corporation, and Chief Operating Officer, AmerisourceBergen Drug Corporation | 619.2K | — | 355.8K | 854.1K | 632.6K | 63.6K | 2.53M | 47.91% | ↗ |
| 196 | 2008 | Michael D. DiCandilo Executive Vice President and Chief Financial Officer | 619.2K | — | 375.6K | 771.8K | 632.6K | 63.6K | 2.46M | 46.59% | ↗ |
| 197 | 2008 | Steven H. Collis Executive Vice President, AmerisourceBergen Corporation, and President, AmerisourceBergen Drug Corporation | 539.8K | — | 338.6K | — | 540.1K | 50.0K | 2.29M | 14.76% | ↗ |
| 198 | 2008 | Steven H. Collis Executive Vice President, AmerisourceBergen Corporation, and President, AmerisourceBergen Specialty Group | 539.8K | — | 338.6K | 824.9K | 540.1K | 50.0K | 2.29M | 50.73% | ↗ |
| 199 | 2008 | Steven H. Collis President and Chief Operating Officer | 539.8K | — | 357.7K | 735.0K | 540.1K | 50.0K | 2.22M | 49.16% | ↗ |
| 200 | 2008 | Jeanne B. Fisher Senior Vice President, Human Resources | 321.0K | — | 114.6K | 278.1K | 316.4K | 33.5K | 1.06M | 36.92% | ↗ |
| 201 | 2008 | Jeanne B. Fisher Senior Vice President, Human Resources | 321.0K | — | 114.6K | — | 316.4K | 33.5K | 1.06M | 10.77% | ↗ |
| 202 | 2008 | John G. Chou Senior Vice President, General Counsel and Secretary | 294.9K | — | 89.4K | 183.8K | 189.9K | 31.0K | 788.8K | 34.63% | ↗ |
| 203 | 2008 | John G. Chou Senior Vice President, General Counsel and Secretary | 294.9K | — | 65.2K | 144.7K | 189.9K | 31.0K | 725.6K | 28.93% | ↗ |
| 204 | 2007 | R. David Yost President and Chief Executive Officer | 1.13M | — | 290.7K | 853.7K | 1.36M | 142.9K | 4.87M | 23.48% | ↗ |
| 205 | 2007 | R. David Yost President and Chief Executive Officer | 1.13M | — | 290.7K | 853.7K | 1.36M | 142.9K | 4.87M | 23.48% | ↗ |
| 206 | 2007 | Kurt J. Hilzinger Former President and Chief Operating Officer | 676.5K | — | 259.5K | 799.2K | 809.3K | 104.0K | 2.82M | 37.58% | ↗ |
| 207 | 2007 | Michael D. DiCandilo Executive Vice President and Chief Financial Officer | 569.2K | — | 221.0K | 629.6K | 653.3K | 66.2K | 2.28M | 37.27% | ↗ |
| 208 | 2007 | Michael D. DiCandilo Executive Vice President and Chief Financial Officer | 569.2K | — | 221.0K | 629.6K | 653.3K | 66.2K | 2.28M | 37.27% | ↗ |
| 209 | 2007 | Michael D. DiCandilo Executive Vice President and Chief Financial Officer, AmerisourceBergen Corporation, and Chief Operating Officer, AmerisourceBergen Drug Corporation | 569.2K | — | 221.0K | 629.6K | 653.3K | 66.2K | 2.28M | 37.27% | ↗ |
| 210 | 2007 | Terrance P. Haas Executive Vice President and Chief Integration Officer | 453.1K | — | 204.2K | 580.4K | 524.4K | 49.8K | 1.88M | 41.74% | ↗ |
| 211 | 2007 | Steven H. Collis Executive Vice President, AmerisourceBergen Corporation, and President, AmerisourceBergen Drug Corporation | 495.4K | — | 210.2K | — | 200.0K | 93.5K | 1.61M | 13.05% | ↗ |
| 212 | 2007 | Steven H. Collis Executive Vice President, AmerisourceBergen Corporation, and President, AmerisourceBergen Specialty Group | 495.4K | — | 210.2K | 611.1K | 200.0K | 93.5K | 1.61M | 51.00% | ↗ |
| 213 | 2007 | Steven H. Collis Executive Vice President and President, AmerisourceBergen Specialty Group | 495.4K | — | 210.2K | 611.1K | 200.0K | 93.5K | 1.61M | 51.00% | ↗ |
| 214 | 2006 | R. David Yost Chief Executive Officer | 1.08M | 1.59M | 470.7K | 97.5K | — | 8.8K | 3.15M | 18.06% | ↗ |
| 215 | 2006 | Kurt J. Hilzinger President and Chief Operating Officer | 647.1K | 869.4K | 434.5K | 90.0K | — | 8.8K | 1.96M | 26.76% | ↗ |
| 216 | 2006 | Michael D. DiCandilo Executive Vice President and Chief Financial Officer | 519.2K | 638.4K | 362.1K | 75.0K | — | 8.8K | 1.53M | 28.59% | ↗ |
| 217 | 2006 | Steven H. Collis Executive Vice President and President, AmerisourceBergen Specialty Group | 456.0K | 477.5K | 344.0K | 71.3K | — | 8.8K | 1.29M | 32.28% | ↗ |
| 218 | 2006 | Terrance P. Haas Executive Vice President and Chief Integration Officer | 397.1K | 360.0K | 325.9K | 67.5K | — | 8.8K | 1.09M | 36.03% | ↗ |
| 219 | 2005 | R. David Yost Chief Executive Officer | 1.04M | 731.3K | — | 170.0K | — | 8.4K | 1.78M | 9.53% | ↗ |
| 220 | 2005 | R. David Yost Chief Executive Officer | 1.04M | 731.3K | — | 85.0K | — | — | 1.78M | 4.79% | ↗ |
| 221 | 2005 | Kurt J. Hilzinger President and Chief Operating Officer | 620.6K | 406.3K | 283.4K | 85.0K | — | — | 1.31M | 28.12% | ↗ |
| 222 | 2005 | Kurt J. Hilzinger President and Chief Operating Officer | 620.6K | 406.3K | — | 170.0K | — | 8.4K | 1.04M | 16.42% | ↗ |
| 223 | 2005 | Steven H. Collis Senior Vice President and President, AmerisourceBergen Specialty Group | 422.3K | 466.7K | — | 60.0K | — | — | 889.0K | 6.75% | ↗ |
| 224 | 2005 | Michael D. DiCandilo Executive Vice President and Chief Financial Officer | 460.6K | 285.0K | — | 120.0K | — | 8.4K | 754.0K | 15.92% | ↗ |
| 225 | 2005 | Michael D. DiCandilo Executive Vice President and Chief Financial Officer | 460.6K | 285.0K | — | 60.0K | — | — | 745.6K | 8.05% | ↗ |
| 226 | 2005 | Terrance P. Haas Senior Vice President and President, AmerisourceBergen Drug Corporation | 369.2K | 206.0K | — | 55.0K | — | — | 575.2K | 9.56% | ↗ |
| 227 | 2004 | Steven H. Collis Senior Vice President and President, AmerisourceBergen Specialty Group | 400.0K | 426.1K | — | 60.0K | — | 1.50M | 2.33M | 2.58% | ↗ |
| 228 | 2004 | R. David Yost Chief Executive Officer | 1.04M | 501.5K | — | 170.0K | — | 8.2K | 1.55M | 10.98% | ↗ |
| 229 | 2004 | R. David Yost Chief Executive Officer | 1.04M | 501.5K | — | 85.0K | — | — | 1.54M | 5.52% | ↗ |
| 230 | 2004 | Kurt J. Hilzinger President and Chief Operating Officer | 584.1K | 322.9K | — | 170.0K | — | 8.2K | 915.2K | 18.58% | ↗ |
| 231 | 2004 | Kurt J. Hilzinger President and Chief Operating Officer | 584.1K | 322.9K | — | 85.0K | — | — | 907.0K | 9.37% | ↗ |
| 232 | 2004 | Michael D. DiCandilo Executive Vice President and Chief Financial Officer | 348.3K | 175.0K | — | 120.0K | — | 8.2K | 531.5K | 22.58% | ↗ |
| 233 | 2004 | Michael D. DiCandilo Senior Vice President and Chief Financial Officer | 348.3K | 175.0K | — | 60.0K | — | — | 523.3K | 11.47% | ↗ |
| 234 | 2004 | Michael D. DiCandilo Executive Vice President and Chief Financial Officer | 348.3K | 175.0K | — | 60.0K | — | — | 523.3K | 11.47% | ↗ |
| 235 | 2004 | Terrance P. Haas Senior Vice President and President, AmerisourceBergen Drug Corporation | 309.3K | 167.9K | — | 50.0K | — | — | 477.1K | 10.48% | ↗ |
| 236 | 2003 | R. David Yost Chief Executive Officer | 960.4K | 995.0K | — | — | — | — | 1.96M | 0.00% | ↗ |
| 237 | 2003 | R. David Yost Chief Executive Officer | 960.4K | 995.0K | — | 100.0K | — | — | 1.96M | 5.11% | ↗ |
| 238 | 2003 | Kurt J. Hilzinger President and Chief Operating Officer | 549.1K | 562.0K | — | 80.0K | — | — | 1.11M | 7.20% | ↗ |
| 239 | 2003 | Kurt J. Hilzinger President and Chief Operating Officer | 549.1K | 562.0K | — | — | — | — | 1.11M | 0.00% | ↗ |
| 240 | 2003 | Steven H. Collis Senior Vice President and President, AmerisourceBergen Specialty Group | 379.2K | 385.0K | — | 40.0K | — | — | 764.2K | 5.23% | ↗ |
| 241 | 2003 | Steven H. Collis Senior Vice President and President, AmerisourceBergen | 379.2K | 385.0K | — | — | — | — | 764.2K | 0.00% | ↗ |
| 242 | 2003 | Michael D. DiCandilo Senior Vice President and Chief Financial Officer | 331.0K | 335.0K | — | — | — | — | 666.0K | 0.00% | ↗ |
| 243 | 2003 | Michael D. DiCandilo Executive Vice President and Chief Financial Officer | 331.0K | 335.0K | — | 55.0K | — | — | 666.0K | 8.26% | ↗ |
| 244 | 2003 | Michael D. DiCandilo Senior Vice President and Chief Financial Officer | 331.0K | 335.0K | — | 55.0K | — | — | 666.0K | 8.26% | ↗ |
| 245 | 2003 | Terrance P. Haas Senior Vice President, Operations | 270.7K | 273.8K | — | — | — | — | 544.5K | 0.00% | ↗ |
| 246 | 2003 | Terrance P. Haas Senior Vice President and President, AmerisourceBergen Drug Corporation | 270.7K | 273.8K | — | 30.0K | — | — | 544.5K | 5.51% | ↗ |
| 247 | 2002 | R. David Yost Chief Executive Officer | 662.5K | 694.7K | — | — | — | — | 1.36M | 0.00% | ↗ |
| 248 | 2002 | R. David Yost Chief Executive Officer | 662.5K | 694.7K | — | 100.0K | — | — | 1.36M | 7.37% | ↗ |
| 249 | 2002 | Kurt J. Hilzinger President and Chief Operating Officer | 428.5K | 450.0K | — | 75.0K | — | — | 878.5K | 8.54% | ↗ |
| 250 | 2002 | Kurt J. Hilzinger President and Chief Operating Officer | 428.5K | 450.0K | — | — | — | — | 878.5K | 0.00% | ↗ |
| 251 | 2002 | Charles J. Carpenter Senior Vice President and President, PharMerica, Inc. | 371.2K | 375.0K | — | — | — | — | 746.2K | 0.00% | ↗ |
| 252 | 2002 | Brent R. Martini Former Executive Officer | 400.0K | 300.0K | — | — | — | — | 700.0K | 0.00% | ↗ |
| 253 | 2002 | Steven H. Collis Senior Vice President and President, AmerisourceBergen | 335.0K | 335.0K | — | — | — | — | 670.0K | 0.00% | ↗ |
| 254 | 2002 | Steven H. Collis Senior Vice President and President, AmerisourceBergen Specialty Group | 335.0K | 335.0K | — | 35.0K | — | — | 670.0K | 5.22% | ↗ |
| 255 | 2002 | Michael D. DiCandilo Senior Vice President and Chief Financial Officer | 248.5K | 300.0K | — | 50.0K | — | — | 548.5K | 9.12% | ↗ |
| 256 | 2002 | Michael D. DiCandilo Senior Vice President and Chief Financial Officer | 248.5K | 300.0K | — | — | — | — | 548.5K | 0.00% | ↗ |
| 257 | 2002 | Terrance P. Haas Senior Vice President and President, AmerisourceBergen Drug Corporation | 221.4K | 230.0K | — | 25.0K | — | — | 451.4K | 5.54% | ↗ |
| 258 | 2002 | Terrance P. Haas Senior Vice President, Operations | 221.4K | 230.0K | — | — | — | — | 451.4K | 0.00% | ↗ |
| 259 | 2001 | R. David Yost Chief Executive Officer | 563.9K | 642.3K | — | — | — | — | 1.21M | 0.00% | ↗ |
| 260 | 2001 | Kurt J. Hilzinger President and Chief Operating Officer | 362.9K | 406.1K | — | — | — | — | 769.0K | 0.00% | ↗ |
| 261 | 2001 | Charles J. Carpenter Senior Vice President and President, PharMerica, Inc. | 350.0K | 335.8K | — | — | — | — | 685.8K | 0.00% | ↗ |
| 262 | 2001 | Brent R. Martini Former Executive Officer | 375.0K | 230.0K | — | — | — | — | 605.0K | 0.00% | ↗ |
| 263 | 2001 | Steven H. Collis Senior Vice President and President, AmerisourceBergen | 300.0K | 259.7K | — | — | — | — | 559.7K | 0.00% | ↗ |
| 264 | 2001 | Terrance P. Haas Senior Vice President, Operations | 186.7K | 231.0K | — | — | — | — | 417.7K | 0.00% | ↗ |
| 265 | 2001 | Michael D. DiCandilo Senior Vice President and Chief Financial Officer | 154.6K | 189.8K | — | — | — | — | 344.4K | 0.00% | ↗ |
| 266 | 2000 | R. David Yost Chief Executive Officer | 525.0K | 592.3K | — | — | — | — | 1.12M | 0.00% | ↗ |
| 267 | 2000 | Kurt J. Hilzinger President and Chief Operating Officer | 340.0K | 370.6K | — | — | — | — | 710.6K | 0.00% | ↗ |
| 268 | 2000 | Brent R. Martini Former Executive Officer | 325.0K | 124.4K | — | — | — | — | 449.4K | 0.00% | ↗ |
| 269 | 2000 | Charles J. Carpenter Senior Vice President and President, PharMerica, Inc. | 300.0K | 135.1K | — | — | — | — | 435.1K | 0.00% | ↗ |
| 270 | 2000 | Steven H. Collis Senior Vice President and President, AmerisourceBergen | 261.3K | 94.1K | — | — | — | — | 355.4K | 0.00% | ↗ |
| 271 | 2000 | Michael D. DiCandilo Senior Vice President and Chief Financial Officer | 136.0K | 115.0K | — | — | — | — | 251.0K | 0.00% | ↗ |
Proxy statements
Recent SEC filings
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Robert Mauch | President, Chief Executive Officer & Director | 6M | — |
| James F. Cleary Jr. | Executive Vice President & Chief Financial Officer | 3M | male |
| Elizabeth S. Campbell | Executive Vice President & Chief Legal Officer | 2M | female |
| Silvana Battaglia | Executive Vice President & Chief Human Resources Officer | 2M | female |
| Pawan Singh Verma | Executive Vice President and Chief Data & Information Officer | — | male |
| Richard Tremonte | EVP and President of U.S. Pharmaceuticals & Animal Health | — | male |
| Lazarus Krikorian | Senior Vice President, Chief Accounting Officer & Corporate Controller | — | male |
| François Mandeville | Executive Vice President and Chief Strategy and M&A Officer | — | male |
| Juan Guerra | EVP & President of International Business Group | — | male |
| Bennett S. Murphy | Senior VP Of Investor Relations & Enterprise Productivity and Treasury | — | male |
| Transaction Date | Disclosed | Representative | District | Owner | Type | Amount | Link |
|---|---|---|---|---|---|---|---|
| 2026-03-31 | 2026-05-01 | Jared Moskowitz | FL23 | — | Purchase | $1,001 - $15,000 | ↗ |
| 2026-03-23 | 2026-05-01 | Jared Moskowitz | FL23 | — | Purchase | $1,001 - $15,000 | ↗ |
| 2025-05-12 | 2025-06-23 | Jefferson Shreve | IN06 | — | Sale | $50,001 - $100,000 | ↗ |
| 2025-03-27 | 2025-04-09 | Greg Landsman | OH01 | Spouse | Sale | $15,001 - $50,000 | ↗ |
| 2024-11-15 | 2024-12-06 | Ro Khanna | CA17 | — | Purchase | $1,001 - $15,000 | ↗ |
| 2024-10-09 | 2024-11-14 | Michael McCaul | TX10 | Spouse | Purchase | $50,001 - $100,000 | ↗ |
| 2024-10-09 | 2024-11-14 | Michael McCaul | TX10 | — | Purchase | $15,001 - $50,000 | ↗ |
| 2024-05-29 | 2024-08-14 | Greg Landsman | OH01 | Spouse | Purchase | $15,001 - $50,000 | ↗ |
| 2024-02-20 | 2024-03-20 | Michael McCaul | TX10 | Spouse | Sale | $50,001 - $100,000 | ↗ |
| 2024-02-20 | 2024-03-20 | Michael McCaul | TX10 | — | Sale | $1,001 - $15,000 | ↗ |
| 2024-01-10 | 2024-02-05 | Ro Khanna | CA17 | — | Purchase | $1,001 - $15,000 | ↗ |
| 2023-09-06 | 2023-10-06 | Ro Khanna | CA17 | Spouse | Sale | $1,001 - $15,000 | ↗ |
| 2023-08-29 | 2023-09-06 | Ro Khanna | CA17 | — | Purchase | $1,001 - $15,000 | ↗ |
| 2023-06-29 | 2023-07-11 | Ro Khanna | CA17 | Spouse | Purchase | $1,001 - $15,000 | ↗ |
| 2023-05-12 | 2023-06-22 | Michael McCaul | TX10 | — | Sale | $15,001 - $50,000 | ↗ |
| 2023-05-12 | 2023-06-22 | Michael McCaul | TX10 | Spouse | Sale | $100,001 - $250,000 | ↗ |
| 2023-03-24 | 2023-04-07 | Ro Khanna | CA17 | — | Sale | $1,001 - $15,000 | ↗ |
| 2023-03-14 | 2023-04-07 | Ro Khanna | CA17 | Spouse | Sale | $1,001 - $15,000 | ↗ |
| 2023-02-10 | 2023-03-08 | Ro Khanna | CA17 | Spouse | Purchase | $1,001 - $15,000 | ↗ |
| 2023-01-25 | 2023-03-02 | Diana Harshbarger | TN01 | — | Purchase | $1,001 - $15,000 | ↗ |
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for COR
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.

MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
